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Summary 
 
Almost all life processes ranging from respiration to metabolism are controlled and 
coordinated by enzymatic reactions. A large repertoire of these enzymes requires 
additional components known as cofactors to achieve optimal activity. Organic cofactors 
or prosthetic groups like heme, siroheme, NAD+ etc. directly participate in the enzymatic 
reactions, thereby bringing about challenging biocatalytic transformations.  While the 
mechanisms of reactions involving cofactors are being studied for decades, their 
biosynthesis, transport and insertion into target enzymes remain largely unknown. This 
study focuses on the synthesis of two such prosthetic groups, the molybdenum cofactor 
(Moco) and heme d1.  
Moco and heme d1 are synthesized via evolutionarily conserved multistep pathway 
involving various enzymatic reactions. This work deals with the structural investigation of 
two enzymes, Cnx1E and NirE, which are implicated in the synthesis of Moco and heme 
d1, respectively. Cnx1E is the N-terminal domain of the protein Cnx1 and catalyzes the 
final step of Moco biosynthesis, whereas NirE is involved in the initial transformation of 
uroporphyrinogen III (uro’gen III) to precorrin-2, which after several further modification 
leads to the formation of heme d1. As a part of this investigation, both the proteins were 
recombinantly expressed in E. coli, purified by affinity chromatography and crystallized 
to obtain single diffracting crystals. While Cnx1E could be crystallized only in its apo 
form, NirE crystallized in apo as well as substrate bound forms.  The crystals were 
subjected to X-ray crystallographic analysis to solve the molecular structure of the 
proteins. 
The structural analysis coupled with functional characterization of NirE and its variants 
concluded in the elucidation of its detailed enzymatic mechanism where two arginine 
residues were identified as catalytically active base and initiator of the methylation of 
uro’gen III, thereby converting the substrate to precorrin-2. The structure of Cnx1E 
revealed its four well-separated domain organization. An interesting discovery made 
from this structure was the high degree of structural similarity of sub-domain 3 of Cnx1E 
to the C-terminal domain of Cnx1 (Cnx1G) leading to the hypothesis that sub-domain 3 
harbors the actual catalytic site of the enzyme. This hypothesis was further explored by 
mutational analysis of two previously identified, functionally relevant residues. In order to 
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reach a definite conclusion regarding the enzymatic mechanism of Cnx1E, it is 
imperative to elucidate the structure of enzyme-substrate complex. This needs further 
investigation.
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Zusammenfassung 
	  
Fast alle Prozesse des Lebens wie Metabolismus und Zellatmung werden durch 
enzymatische Reaktionen koordiniert und kontrolliert. Viele Enzyme benötigen 
zusätzliche Moleküle, Kofaktoren genannt, für die optimale Aktivität. Organische 
Kofaktoren oder prosthetische Gruppen wie Häm, Sirohäm, NAD+ partizipieren direkt in 
enzymatischen Reaktionen, um komplizierte biokatalytische Umwandlungen zu 
ermöglichen. Während die Reaktionsmechanismen, in die Kofaktoren involviert sind, oft 
seit Jahrzehnten erforscht werden, ist über deren Biosynthese, Transport und Einbau in 
ihr Enzym meist sehr wenig bekannt. Diese Arbeit befasst sich mit der Synthese zweier 
solcher prosthetischer Gruppen, dem Molybdänkofaktor (Moco) und Häm d1. 
Moco und Häm d1 werden in mehreren Schritten hergestellt über einen evolutionär 
konservierten Syntheseweg, der verschiedene enzymatische Reaktionen beinhaltet. In 
dieser Arbeit wurden die Strukturen von zwei Enzymen, Cnx1E and NirE, aufgeklärt, die 
in der Synthese von Moco and heme d1 involviert sind. Cnx1E ist die N-terminale 
Domäne des Proteins Cnx1 und katalysiert den finalen Schritt in der Moco Biosynthese, 
während NirE an der initialen Umwandlung von Uroporphyrinogen III (Uro’gen III) zu 
Precorrin-2 beteiligt ist, welches durch weitere Reaktionsschritte zu  Häm d1 umgwandelt 
wird. In dieser Arbeit wurden beide Proteine rekombinant in E. coli exprimiert, über 
Affinitätschromatographie gereinigt und kristallisiert. Während Cnx1E nur in der apo-
Form kristallisiert werden konnte, wurde NirE sowohl ohne als auch mit gebundenem 
Kofaktor kristallisiert werden. Die molekulare Struktur der beiden Proteine wurde mittels 
Röntgenkristallographie aufgeklärt. 
 Die Strukturaufklärung zusammen mit der funktionellen Charakterisierung von NirE und 
Varianten davon erlaubte die Aufklärung des enzymatischen Mechanismus. Dabei 
agieren zwei Argininreste als katalytisch aktive Base und als Initiator der Methylierung 
von Uro’gen III, wodurch das Substrat zu Precorrin-2 umgewandelt wird. Die Struktur 
von Cnx1E zeigte, dass das Protein in vier separate Domänen aufgeteilt ist. 
Interessanterweise ist die Struktur der Domäne 3 sehr ähnlich zu der C-terminalen 
Domäne von Cnx1 (Cnx1G), was zu der Hypothese führt, dass die Domäne 3 für die 
tatsächliche katalytische Aktivität zuständig ist. Diese Hypothese wurde weiter 
untersucht durch die Analyse von zwei Mutanten von zwei bekannten, funktionell 
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relevanten Aminosäuren. Um jedoch eine definitive Aussage über den 
Reaktionsmechanismus von Cnx1E treffen zu können, wäre es notwendig die Struktur 
von Cnx1E im Komplex mit seinem Substrat aufzuklären.  
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Abbreviations 
3D 3 Dimensional 
Aba3 (+)-abscisic acid 8'-hydroxylase 
ALA 5-aminolevulinic acid  
AMP Adenosine monophosphate 
AMP Adenosine mono phosphate 
AP Alkaline phosphate 
APS Ammonium persulfate 
Cnx Cofactor for nitrate reductase and xanthine dehydrogenase 
CobA Cobalt-precorrin 5A hydrolase 
cPMP cyclic pyranopterin 
CysG 5-methyltetrahydrofolate--homocysteine S-methyltransferase 
ddH2O Distilled water 
DMSOR Dimethyl sulfoxide reductase 
E. Coli Escherichia coli 
FAD Flavin adenine dinucleotide 
FeMoco Iron molybdenum cofactor 
GTP Guanosine-5'-triphosphate 
H2SO4 Sulfuric acid 
HCl Hydrochloric acid 
Hepes 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
HPLC High pressure liquid chromatography 
IPTG Isopropyl-β-D-thiogalactopyranoside 
KI Kotassium iodide 
LB Luria-Bertani broth 
MCP Moco carrier protein 
Met1 Methionine S-methyltransferase 
MgCl2 Magnesium chloride 
Moco Molybdenum cofactor 
MPT Molydopterin 
MPT Molydopterin 
NaCl Sodium chloride 
NAD Nicotinamide adenine dinucleotide 
NirE Nitrite reductase protein encoded by nirE gene 
PDB Protein data bank 
PEG Polyethylene glycol 
RLD Rhodonase like domain 
SAH S-adenosyl-homocysteine 
SAM S-adenosyl-L-methionine 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SirA Sirohydrochlorin ferrochelatase 
SUMT SAM dependent uroporphyrinogen III methyl transferase 
TEMED Tetramethylethylenediamine 
TLS Translation Libration Screw-motion 
Tris Trisaminomethane 
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E. coli Escherichia coli 
MoO42- Molybdate 
[Fe-S] Iron sulfur cluster 
ATP Adenosine triphosphate 
Mg Magnesium 
Ni Nickel 
Co Cobalt 
NO Nitric oxide 
Cu Copper 
Fe Iron 
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1A.1. Molybdenum Enzymes 
Molybdenum is one of the most abundant transition elements on Earth. Although it 
makes up only a small fraction of the earth’s crust, it is readily available in sea water and 
as molybdate (MoO42-) (Hille, 2002). Upon cellular uptake, MoO42- is incorporated into 
metal cofactors by a conserved biosynthetic pathway (Dos Santos et al., 2004, Schwarz, 
2005). These cofactors form an essential component of the active site of molybdenum 
enzymes that play a cardinal role in the biogeochemical redox cycles of carbon, nitrogen 
and sulfur on earth, as well as in the metabolism of every individual organism. The 
versatile redox chemistry of molybdenum is extensively exploited by these enzymes to 
catalyze redox reactions (Hille, 2002). This is essentially achieved by the three oxidation 
states of molybdenum (+4, +5 and +6), thereby enabling the enzymes to catalyze two-
electron reduction/oxidation reactions. With the exception of Saccharomyces cerevisiae, 
molybdenum enzymes are found in all organisms (Zhang et al., 2008). Up till now, more 
than 50 molybdenum enzymes have been discovered. 
Based on the catalytic functions and on the type of cofactor, these enzymes are broadly 
divided into two categories. The first category consists of the iron-molybdenum cofactor 
(FeMoco) containing bacterial nitrogenases and the second group is composed of 
enzymes harboring pterin-based cofactors (Moco). Both these types of molybdenum 
cofactors share similar metal ion coordination where molybdenum is coordinated by 
three sulfur and two oxygen atoms. The first type, FeMoco, is an iron-sulfur-cluster 
based iron-molybdenum cofactor where one [4Fe-3S] and one [Mo-3Fe-3S] are linked 
by a partial cubane bridge of three sulfides and one µ6 central atom, X (which could be 
carbon, oxygen or nitrogen) (Figure 1A) (Einsleet al., 2004). The other type of 
molybdenum cofactor, known as Moco, is a pterin based cofactor, which contains a C-6 
substituted pyrano ring, a terminal phosphate and a unique dithiolate group that 
participates in the coordination of molybdenum (Rajagopalan & Johnson, 1992). The 
metal can be attached to one or two pterin moieties with additional terminal oxygen and 
sulfur ligands. The latter category of enzymes is further classified into three families: 
dimethyl sulfoxide reductase (DMSOR), sulfite oxidase and xanthine oxidase. Each of 
these enzyme families has a distinct active-site structure (Hille, 2002). The chemical and 
three-dimensional structures of different molybdenum cofactors are shown in Figure 1. 
This work focuses on the biosynthesis of Moco belonging to the xanthine oxidase family 
of plant enzymes. 
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A 
B 
C 
D 
Figure 1: Molybdenum cofactors. The structures of four different types of molybdenum cofactors, which are the 
basis of classification of molybdenum enzymes, are shown. Schematics are shown on the left-hand side, full 3D 
structure are represented by balls-and-sticks on the right-hand site. (A) FeMoco of molybdenum nitrogenase from 
Azobacter vinelandii (PDB ID–1N2C), (B) Moco of DMSOR from Rhodobacter sphaeroides (1EUI) (C) Moco of 
chicken sulphite oxidase (3R18), (D) Moco of bovine xanthine oxidase (1FIQ). 
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 Xanthine oxidase family of enzymes - Enzymes belonging to the xanthine oxidase 
family are also known as molybdenum hydroxylases due to their catalytic function in 
hydroxylation reaction. They are known to catalyze the hydroxylation of the carbon 
centers in aldehydes and aromatic heterocycles (Hille, 2005). Members of this family are 
represented by xanthine oxidase, xanthine dehydrogenase and aldehyde oxidase. 
These enzymes play a key role in purine degradation (Schwarz et al., 2009). In plants, 
they are also believed to be involved in pathogen defense (Montalbini, 1992) and ageing 
(Pastori and Del Rio, 1997). The crystal structures of several members of this enzyme 
family have been elucidated including bovine xanthine oxidase (Enroth et al., 2000) and 
human xanthine oxidase (Yamaguchi et al., 2007). These structures revealed that 
eukaryotic xanthine oxidase and xanthine dehydrogenase assemble as homodimers 
having three distinct domains in each monomer. Apart from Moco, each of the 
monomers also harbors two iron-sulfur centers and one FAD cofactor for electron 
transfer. The Moco binding domain is involved in and is essential for the dimerization 
and hence constitution of the enzyme. Figure 2 shows the structure of the homodimeric 
bovine xanthine oxidase along with the three different cofactors. 
 
 
 
Figure 2: Crystal structure of xanthine oxidase from bovine milk. The homodimer of bovine xanthine 
oxidase is shown in cartoon representation (PDB ID-1FIQ). One of the monomers is shown with higher 
transparency to provide a clear view of the cofactors that are buried deep within the molecule. FAD and 
Moco are shown as sticks whereas the iron sulfur clusters are shown as spheres. The three different 
domains of each subunit are differentiated by colors. The FAD binding domain is shown in green, the 
domain harboring the iron sulfur clusters is shown in red and the Moco binding domain, which is also the 
dimerizing domain, is shown in blue (Enroth et al., 2000).  
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1A.2. Moco biosynthesis 
Moco biosynthesis takes place through a highly conserved pathway comprising of four 
major steps (Schwarz, 2005). It starts with GTP and involves the formation of the 
intermediates precursor Z, molybdopterin (MPT), adenylated MPT (MPT-AMP) and 
finally Moco (Schwarz, 2005). Figure 3 depicts the four major steps of the Moco 
biosynthetic pathway in plants, along with the key enzymes involved in the numerous 
catalytic reactions. These enzymes share a common Cnx nomenclature that is derived 
from their overall function in the synthesis of cofactor for nitrate reductase and xanthine 
dehydrogenase. Moco is a very labile and oxygen sensitive molecule. Once synthesized, 
it cannot exist in a free state and has to be coupled to another protein (Rajagopalan & 
Johnson, 1992). Thus, it is either transferred to the molybdenum enzymes or is 
complexed to a carrier protein (MCP), which stores the cofactor until further use. Another 
possibility at this stage is to transfer Moco to the Moco sulfurase protein (Aba3), which 
further sulfurates it before it can be used as a cofactor by enzymes of the xanthine 
oxidase family (Bittner et al., 2001, Mendel and Bittner, 2006). The individual steps of 
Moco biosynthesis in plants are discussed below in detail. 
 
 
Figure 3: Moco Biosynthesis pathway, distribution and maturation in plant cell. The steps of Moco 
biosynthesis pathway starting from GTP to Moco, along with the intermediates and the enzymes catalyzing 
the individual steps are depicted. (Figure modified from Mendel and Bittner, 2006) 
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Conversion of GTP to cyclic pyranopterin (cPMP) - Moco biosynthesis starts with the 
conversion of GTP to cyclic pyranopterin (cPMP), which was initially named precursor Z 
(Wuebbens and Rajagopalan, 1993). In plants, this step is catalyzed by two enzymes, 
Cnx2 and Cnx3 (Figure 4). Cnx2 is a S-adenosyl-L-methione (SAM) enzyme and 
harbors two [4Fe-4S] clusters, one at the N-terminal end and the other at the C-terminal 
end. The [4Fe-4S] at the N-terminal end is involved in the generation of radical SAM and 
the C-terminal [4Fe-4S] cluster is involved in substrate binding (Hanzelmann and 
Schindelin, 2006). The second enzyme (Cnx3) is a hexameric protein and plays a role in 
the release of the pyrophosphate. The detailed reaction mechanism of this step is a 
subject of current research and a conclusive understanding regarding the enzymatic 
catalysis is yet to be reached. However, it has been proven that cPMP contains all the 
carbon atoms of the GTP-derived ribose and purine (Hanzelmann and Schindelin, 2006, 
Wuebbens and Rajagopalan, 1995). The cPMP molecule is a completely reduced 
pyranopterin with a terminal cyclic phosphate and a geminal diol.  
 
 
 
 
Figure 4: Conversion of GTP to cyclic pyranopterin (cPMP). Schematic representation of the conversion 
of GTP to cPMP, catalyzed by the enzymes Cnx2 and Cnx3 in plants. 
 
 
Synthesis of molybdopterin dithiolate (MPT) - The second step in Moco biosynthesis is 
the conversion of cPMP to molybdopterin dithiolate (MPT) catalyzed by the enzyme MPT 
synthase (Figure 5). MPT synthase is a heterotetrameric assembly of two small and two 
large subunits (Schwarz et al., 2009). In plants, this tetrameric assembly has been 
suggested to be composed of Cnx6 (small subunit) and Cnx7 (large subunit) (Schwarz, 
2005). For the formation of MPT dithiolate, two sulfur atoms need to be incorporated into 
cPMP. These two sulfur atoms come from the two small subunits where it is bound at 
the C-terminal double glycine motif (Gutzke et al., 2001). The original source of the 
GTP cPMP 
Cnx2 
Cnx3 
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sulfur atoms is not yet known. This motif is buried deep inside the large subunit to form 
the active center of the enzyme (Rudolph et al., 2001). Owing to the presence of only 
one sulfur atom per molecule, this reaction has been proposed to proceed through a 
two-step mechanism via a monosulfurated intermediate (Wuebbens et al., 2003). An 
unexpected discovery regarding the MPT molecule synthesized at this step, was the 
existence of a bound copper to the dithiolate sulfurs (Kuper et al., 2004).  
Once the sulfur atoms have been transferred to cPMP, the desulfo-Cnx7 is catalytically 
regenerated by MPT synthase sulfurase (Figure 5). This is brought about by the 
adenylation of the C-terminal glycine residue and is followed by sulfuration by a cysteine 
desulfurase. In plants, these two steps of adenylation and sulfuration are performed by 
the enzyme Cnx5 (Matthies et al., 2004, Matthies et al., 2005). Cnx5 is a two domain 
protein where the N-terminal domain is responsible for the adenylation of MPT sulfurase, 
followed by sulfuration by the C-terminal rhodanese-like protein (RLD) (Matthies et al., 
2005). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 5: Conversion of cPMP to MPT. The cPMP is converted to MPT by the enzyme MPT synthase 
which is a heterotetrameric complex of two large subunits Cnx6 and two small subunits Cnx7. Each 
molecule of Cnx7 has one sulfur atom bound. Following each sulfuration by MPT synthase, it is regenared 
by MPT synthase sulfurase. 
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Adenylation of MPT - The synthesis of MPT completes the skeleton of the cofactor. The 
next step involves the insertion of the molybdenum metal into MPT to form Moco. 
Hence, this step is the crosslink between the MoO42- uptake system and the MPT 
synthesis pathway. Molybdenum is incorporated into MPT by a two step reaction. In 
bacteria, two enzymes, MogA and MoeA are involved in the two steps of this reaction 
(Schwarz, 2005). However, upon evolution to eukaryotes, these two enzymes have been 
fused to form one single protein molecule with two domains. In plants, this enzyme is 
known as Cnx1 (Schwarz et al., 1997, Schwarz et al., 2001). Cnx1 is composed of a C-
terminal G-domain (Cnx1G) and an N-terminal E-domain (Cnx1E). The names of the 
domains Cnx1G and Cnx1E are derived from the bacterial homologues MogA and 
MoeA, respectively. The structures of wildtype Cnx1G and Cnx1G variants in complex 
with its substrate and product have already been solved (Kuper et al., 2004, Kuper et al., 
2006). 
The structure of wildtype Cnx1G in complex with its substrate MPT (PDB ID-1UUX), 
revealed the existence of the copper molecule bound to the dithiolate sulfurs. The exact 
role of this copper is yet to be ascertained. It has been speculated that the copper atom 
is involved in protecting the MPT dithiolate from oxidation. Additionally, it could also be 
possible that the copper atom presents an appropriate exit group for the insertion of 
molybdenum (Mendel and Bittner, 2006). 
 
The physiological function of the Cnx1 enzyme was elucidated from the X-ray 
crystallographic analysis of Cnx1G variants (Kuper et al., 2006).  An important discovery 
made from the structure of Cnx1G variant S583A (PDB ID-1UUY), was the existence of 
the novel intermediate MPT-AMP bound at the catalytic site. The adenosine molecule 
was found to be linked to the C-4 carbon of the MPT moiety via a phosphate bond. 
Hence, the role of Cnx1G was established as an adenylation enzyme that activates MPT 
by adenylation to form MPT-AMP in Mg2+ and ATP dependent manner. Figure 6A shows 
the crystal structure of Cnx1G in complex with its substrate, MPT, whereas Figure 6B 
shows the structure of Cnx1G S583A variant in complex with its product, MPT-AMP. The 
chemical reaction catalyzed by Cnx1G is depicted in Figure 6C. 
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Figure 6: Crystal structures of and the reaction catalyzed by Cnx1G from Arabidopsis thaliana. 
Structure of Cnx1G in complex with its substrate MPT (PDB ID-1UUX)(A) and the product MPT-AMP 
(1UUY) (B). In both the figures, Cnx1G is shown in cartoon representation whereas the substrate MPT and 
the product, MPT-AMP bound at the active site are represented by sticks (Kuper et al., 2004). (C) 
Adenylation of MPT to MPT-AMP catalyzed by Cnx1G. 
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Insertion of molybdenum and crosstalk with copper metabolism - In the fourth and final 
step of the Moco biosynthesis pathway, MPT-AMP is converted to mature Moco. MPT-
AMP formed in the previous step by the C-terminal Cnx1G is transferred to the N-
terminal Cnx1E, thus establishing a product-substrate channel (Figure 7). Cnx1E 
hydrolyses MPT-AMP, releases the copper and subsequently inserts a molybdenum 
atom in the form of MoO42-, thereby leading to the formation of mature Moco (Schwarz et 
al., 2009). The structural analysis of Cnx1E is one of main objectives of this work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Domain organization of Cnx1. The domain organization of Cnx1 where Cnx1G catalyzes the 
adenylation of MPT in a Mg2+ ATP dependent manner whereas the Cnx1E catalyzes the hydrolysis of MPT-
AMP with the subsequent release of copper and insertion of molybdenum. The reaction catalyzed by Cnx1E 
is dependent on the presence of MoO42- and divalent cations like Mg2+. 
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1A.3. Functional role of Cnx1E 
The Cnx1E protein in plants is a 48 kDa protein that is involved in the last and final step 
of Moco biosynthesis. Previously, it was believed that one domain of Cnx1 is involved in 
the generation of active molybdenum which is incorporated into MPT by the other 
domain. However, with the discovery of the novel intermediate MPT-AMP as the product 
of Cnx1G, the question arose about the functional role of Cnx1E. In vitro studies 
involving the Cnx1G loaded with MPT-AMP demonstrated the synthesis of Moco upon 
addition of Cnx1E in the presence of Mg2+ ions (Kuper et al., 2004). This suggested that 
Cnx1E is involved in the insertion of molybdenum. Further experiments revealed that in 
the presence of molybdate, Cnx1E is capable of hydrolyzing MPT-AMP and 
simultaneously performing metal exchange by releasing the bound copper and inserting 
molybdenum into MPT, thereby producing mature Moco (Mendel group, unpublished 
results). However, very little is known about this reaction step, much of which is 
speculation. 
In order to answer the questions regarding this novel mechanism of nucleotide assisted 
molybdenum insertion, structural information is required which would help to fill the 
current gap in knowledge. A structure of apo Cnx1E as well as the enzyme-substrate 
complex of Cnx1E with MPT-AMP is the only means to obtain a detailed structural 
overview of the active site of the enzyme that would help in identifying the functionally 
relevant amino acids involved in the catalytic activity. This would ultimately lead to the 
answers regarding the enzymatic mechanism of Cnx1 and thus provide a detailed 
understanding of the last two steps of Moco biosynthesis. With this objective, the present 
work aimed at studying the structure-function relationship of Cnx1E molecule and couple 
it with the knowledge gained from the structure of Cnx1G (Kuper et al., 2006) to arrive at 
a definite conclusion on the functional role of Cnx1E. 
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1B. Role of NirE in the synthesis of the tetrapyrrole heme d1 
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1B.1. Tetrapyrroles 
As evident from their name, tetrapyrroles are comprised of four pyrrole rings. The pyrrole 
rings are either linearly attached to one another or arranged in a cyclic fashion in the 
form of a macrocycle. In the case of porphyrins, they form a macrocycle where the four 
pyrrole rings are joined by covalent bonds via four unsaturated methine bridges by one-
carbon units linking position 2 of one pyrrole ring to position 5 of the next (Figure 8). 
Tetrapyrroles play a cardinal role in many biological processes such as photosynthesis 
and respiration. Through various modifications, they form a family of structurally related 
metallo-prosthetic groups. 
 
Figure 8: Macrocyclic ring system of porphyrin as the backbone of tetrapyrroles. The pyrrole rings are 
denoted A-D in a clockwise orientation, carbon and nitrogen atoms are numbered. α-position: carbon atoms 
next to nitrogen-atoms, β-position: position of substituents, carbon-atoms without direct contact to nitrogens, 
meso-position: carbon-atoms of methine bridges. (Figure adopted from Sonja Storbeck, PhD Thesis,  2011) 
 
Up till now, numerous naturally occurring tetrapyrroles have been deciphered. They can 
be distinguished from each other based on three characteristics. Firstly, the oxidation 
states of the macrocyclic ring system; secondly, the nature of the side chains through 
which they interact with the proteins; and finally, the type of the chelated divalent metal 
ion e.g. Fe2+, Co2+, Mg2+ or Ni2+. This diversity enables them to perform their specific 
biological function and participate in various enzymatic reactions (Jahn et al., 1996). 
Apart from the macrocycles, linear tetrapyrroles like bilirubin also exist which are derived 
by the oxidative cleavage of the macrocycle. 
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Tetrapyrroles play a major role as prosthetic groups of metallo-enzymes, thereby 
participating in numerous bio-catalytic reactions. Magnesium containing chlorophylls and 
bacteriochlorophylls convert light to chemical energy during the process of 
photosynthesis (Allen and Williams, 1998, Beale, 1999). Coenzyme F430, harboring the 
metal nickel, forms an essential cofactor of methyl-coenzyme M reductase that is 
involved in the formation of methane (Ermler, 2005, Whitman and Wolfe, 1980). Cobalt 
containing Cobalamin (vitamin B12) participates in numerous metabolic processes that 
include methylation, reduction and diverse rearrangements (Martens et al., 2002, Raux 
et al., 2000). Linear tetrapyrroles like bilins do not consist of a central metal ion but still 
play a role in photosynthesis by acting as chromophores (Dammyer and Frankenberg-
Dinkel, 2008). Among the iron containing tetrapyrroles, the most important is heme, 
which is an essential component of hemoglobin that accomplishes the complex task of 
respiration by its ability to transfer oxygen and exchange gases at cellular level. 
Siroheme, which also contains iron, is a cofactor of sulfite and nitrite reductases, and is 
responsible for the catalytic activity of these enzymes in the reduction of sulfite and 
nitrite (Crane et al., 1997). Finally, heme d1 is another iron-containing tetrapyrrole that is 
involved in denitrification and is the major subject of this investigation. Figure 9 shows 
the chemical structures of important naturally occurring tetrapyrroles along with their last 
common precursor uroporphyrinogen III (uro’gen III). 
 
1B.2. Uroporphyrinogen III: The last common precursor of tetrapyrroles 
Tetrapyrrole biosynthesis takes place through a highly conserved, branched, multistep 
pathway and involves numerous enzymatic reactions including porphyrin ring oxidation, 
decarboxylation, metal ion chelation and methylation. All naturally occurring tetrapyrroles 
share their initial steps of synthesis starting with 5-aminolevulinic acid (ALA) as the first 
precursor (Heinemann et al., 2008). ALA is converted to the final common precursor 
uro’gen III by three enzymatic steps that are common to the synthesis of all 
tetrapyrroles. From uro’gen III, the tetrapyrrole biosynthesis pathway splits into two, one 
leading to the intermediate coproporphyrinogen III which is further converted to heme 
and chlorophyll and the other route leading to the formation of precorrin-2 which 
concludes in cobalamin, coenzyme F430, siroheme and heme d1. 
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Figure 9: Chemical structures of important representatives of naturally occurring tetrapyrroles. All 
shown tetrapyrroles share uro’gen III as their last common precursor. The chelated divalent metal ion is 
denoted next to the arrow. (Figure modified from Sonja Storbeck, PhD Thesis, 2011) 
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1B.3. Heme d1, an essential prosthetic group of the nitrite reductase 
Under anaerobic conditions, several species of bacteria such as Pseudomonas and 
Clostridium use denitrification as an alternate form of respiration. It consists of four 
enzyme catalyzed reaction steps via which nitrate is reduced to di-nitrogen. In the first 
step, nitrate is reduced to nitrite catalyzed by the enzyme nitrate reductase. The nitrite 
thus formed is converted to nitric oxide in the second step by the enzyme nitrite 
reductase. The third step involves the reduction of nitric oxide to nitrous oxide by nitric 
oxide reductase and finally, in the last step, nitrous oxide reductase converts nitrous 
oxide to molecular nitrogen. The tetrapyrrole heme d1 serves as an essential prosthetic 
group of the cytochrome cd1 nitrite reductase that catalyzes the second step of the 
denitrification process in denitrifying bacteria such as Pseudomonas denitrificans, 
Paracoccus pantotrophus or the human pathogen Pseudomonas aeruginosa. 
 
Nitrite reductases are classified into two groups based on their cofactors. One group 
contains copper as its cofactor and the other having the cofactors heme c and heme d1. 
In 1991, the crystal structure of a copper containing nitrite reductase from 
Achromobacter cycloclastes was solved, which revealed that the enzyme exists as a 
homotrimer and contains two types of copper centers (Godden et al., 1991). The first 
type of copper center donates electrons to the second type where the actual catalysis 
takes place (Ferguson, 1994). 
The second group of nitrite reductase contains the cofactors heme c and heme d1 and 
its members have been appropriately named cytochrome cd1 nitrate reductase. The 
enzyme was first recognized for its oxygen reductase activity (Horio et al., 1961) and 
later for its ability to reduce nitrite (Yamanaka et al., 1961). Similar to its counterpart, 
cytochrome cd1 nitrate reductase is also a periplasmic enzyme. However, it differs from 
the copper containing nitrite reductase in its oligomeric assembly, as it exists as a 
homodimer. Figure 10 shows the crystal structure of the NirS dimer from Pseudomonas 
aeruginosa (PDB ID-1NIR) (Nurizzo et al., 1997).  
In the dimeric structure of NirS (Figure 10), the N-terminal end of one monomer extends 
into the active site of the other monomer. Each monomer is composed of two unequally 
sized sub-domains. The smaller sub-domain harbors a covalently bound heme c 
whereas heme d1 is non-covalently bound to the larger sub-domain. The substrate binds 
INTRODUCTION 
 
 24 
to the larger sub-domain through the interaction of its nitrogen atom with the ferrous 
atom of heme d1 (heme d1-Fe3+NO). The mechanism of this enzymatic reaction involves 
the transfer of a single electron from heme c to the substrate via heme d1 (Cutruzzola et 
al., 2003, Einsle and Kroneck, 2004). In the case of NirS, this electron is donated by 
cytochrome C551 (Vijgenboom et al., 1997). An isoelectric nitrosylintermediate, heme d1-
Fe2+NO+ to heme d1-Fe3+NO was found to exist (Kim and Hollocher, 1983).  Heme d1-
Fe3+NO was found to be chemically unstable and releases NO from the active site. 
Biochemical investigation based on NirS mutants revealed that the anionic ligands like 
nitrite are stabilized in the active site by two conserved histidine residues that also play a 
role in the release of the reaction product, nitric oxide (Cutruzzola et al., 2001, Sun et al., 
2002). The cofactor heme d1 plays the cardinal role in this catalytic reaction and forms 
an essential and unique component of NirS. 
 
 
Figure 10: Crystal structure of cytochrome cd1 nitrite reductase from Pseudomonas aeruginosa. The 
structure of cytochrome cd1 nitrite reductase (NirS) is shown in cartoon representation (PDB ID-1NIR). One 
of the monomer units of dimeric NirS is shown in higher transparency to provide a clear view of the cofactors 
that are buried deep within the molecule. Each monomer is divided into a small domain harboring heme c 
(green) and a large domain harboring heme d1 (gray) (Nurizzo et al., 1997). 
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1B.4. Biosynthesis of Heme d1 
Similar to several other tetrapyrroles like siroheme and cobalamin, synthesis of heme d1 
also follows the route of precorrin-2 from uro’gen III. Previous research based on isotope 
labeling revealed that the carbon skeleton of heme- d1 is derived from ALA (Matthews 
and Timkovich, 1993). Additional experiments involving radioactive labeling of SAM 
further showed that the methyl groups at rings A and B originate from SAM (Yap-
Bondoc, et al., 1990). It has also been proved that the chiral centers at positions C-2 and 
C-7 possess the same configuration as in siroheme and cobalamin, the latter of which 
also includes the cis configuration of the methyl groups (Aucken et al., 1997, Mackman 
et al., 1997, Micklefield et al., 1997). Hence, it was concluded that the biosynthetic 
pathway of heme d1 coincides with several reaction steps of siroheme and cobalamin 
biosynthesis. The route of heme d1 biosynthesis can be summarized as follows: uro'gen 
III is first methylated at positions C-2 and C-7, followed by the oxidation of the 
macrocycle and insertion of a divalent iron. Then, the acetate groups at positions C-12 
and C-18 are decarboxylated, the propionate groups are removed from C-3 and C-8 and 
oxo-groups are introduced at these positions. Finally, an acrylate side chain is formed at 
C-17, thus completing the synthesis of heme d1.   
 
In Pseudomonas aeruginosa, a set of genes known as the nir genes have been 
identified, many of which encode enzymes involved in the biosynthesis of heme d1. 
Figure 11 shows the organization of nir genes in the nir-operon as suggested by 
Kawasaki (Kawasaki et al., 1997). The first gene, nirS, encodes the cytochrome cd1 
nitrite reductase NirS. Based on mutational analysis, it was proposed that the genes 
nirF-E encode enzymes that are responsible for heme d1 biosynthesis (Kawasaki et al., 
1997).  
 
The protein encoded by nirF was found to exhibit 35% sequence identity to NirS (Bali et 
al., 2010, Timkovich, 2002). This protein was also found to possess a lysine rich motif 
that could be involved in the binding of nucleotides (Scrutton et al., 1990). Additionally, it 
was also seen that in Paracoccus pantotrophus, NirF is a periplasmic protein carrying an 
N-terminal signal sequence for Sec dependent translocation. In Pseudomonas 
aeruginosa, NirF was found to possess a signal sequence generally associated with the 
liproproteins of the cytoplasmic membrane (Sonja Storbeck, PhD Thesis, 2011). On the 
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basis of these results, it was proposed that NirF is a periplasmic protein with a functional 
role during the late steps of heme d1 synthesis (Bali et al., 2010). 
The genes nirD, nirL, nirG and nirH encode proteins that show pair wise sequence 
identity, with NirD and NirG having 45% and NirL and NirH 35% identity. It was 
suggested that these enzymes form a heterotetrameric complex (Timkovich, 2002), 
which was also seen by protein interaction studies (Sonja Storbeck, PhD Thesis, 2011). 
These four proteins were found to play the role of transcriptional regulators of the nirJEN 
genes (Sonja Storbeck, PhD Thesis, 2011). In addition, these proteins have also been 
shown to catalyze the decarboxylation of the acetate groups at positions C-12 and C-18 
of siroheme to corresponding methyl groups (Bali et al., 2011). 
The enzyme encoded by the next gene of the operon, nirJ, belongs to the radical SAM 
protein family (Brindley et al., 2010, Sofia et al., 2001). It harbors the typical CXXXCXXC 
consensus sequence required for the coordination of a [4Fe-4S] cluster that aids in the 
conversion of SAM to 5’-deoxyadenosyl radical by furnishing an electron (Wang and 
Frey, 2007). Such radical based reaction mechanisms are characteristic of challenging 
chemical transformations. NirJ is believed to be involved in attaching the oxo-groups at 
positions C-3 and C-8 (Zumft, 1997). 
Finally, the nirE gene encodes a SAM dependent uro’gen III methyltransferase (SUMT), 
which was proposed to be involved in the methylation of uro'gen III at positions C-2 and 
C-7 to yield precorrin-2. This hypothesis was based on the high level of sequence 
identity of NirE with CobA from Pseudomonas denitrificans and CysG from E. coli and 
Salmonella typhimurium (Timkovich, 2002). 
 
 
 
 
Figure 11: The nir genes as organized in the nir-operon of Pseudomonas aeruginosa. The brown 
arrows represent the genes of the nir-operon with the corresponding name of the gene denoted within. 
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1B.4.1. Working model for heme d1 biosynthesis 
On the basis of the above hypothesis of the functional role of enzymes encoded by the 
nir operon, a model for the biosynthesis of heme d1 can be proposed (Figure 12). In this 
model, heme d1 biosynthesis starts with ALA that is converted to uro'gen III by the 
enzymes HemB, HemC and HemD. From this point, the heme d1 synthesis route 
branches off. At first, uro'gen III is converted to precorrin-2 in a SAM dependent 
methylation reaction catalyzed by NirE. Following this, precorrin-2 is oxidized by a 
dehydrogenase to yield sirohydrochlorin, which is then acted upon by a ferrochelatase to 
insert an iron, thus converting sirohydrochlorin to siroheme. Currently, the source of the 
dehydrogenase and ferrochelatase is not known. In the next step, siroheme is converted 
to 12,18-di-decarboxysiroheme by a decarboxylation reaction possibly catalyzed by the 
tetrameric complex of NirDLGH. This is followed by the addition of two oxo-groups at 
positions C-3 and C-8 by the enzyme NirJ, thereby yielding 3,8-dioxo-12,18-dicarboxy-
siroheme. Finally, an acrylate side chain is formed at C-17 by the enzyme NirF, thereby 
producing heme d1.  
 
The NirE catalyzed conversion of uro’gen III to precorrin-2 in a SAM dependent 
methylation reaction is one of the central themes of this investigation and has been 
studied in detail through this work. An attempt was made to understand the mechanism 
of this reaction from a structural aspect of the enzyme, NirE. This has been described 
further in this thesis. 
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Figure 12: Working model for heme d1 biosynthesis. The working model for heme d1 biosynthesis shows 
the conversion of uro’gen III to precorrin-2 by NirE. Further steps lead to the oxidation of precorrin-2 to 
sirohydrochlorin and iron insertion to yield siroheme. It is presumed that NirDLGH catalyzes the 
decarboxylation of siroheme resulting in the formation of 12,18-didecarboxy-siroheme. Following this, NirJ 
generates the oxo-groups through a potential radical mechanism. Finally, the formation of an acrylate by 
NirF in a dehydrogenation reaction completes the synthesis. (Figure adopted from Sonja Storbeck, PhD 
Thesis, 2011) 
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1B.4.2. SAM dependent methylation of uro’gen III  
Heme d1 biosynthesis, as discussed in the previous section, proceeds through precorrin-
2, produced by the methylation of uro’gen III at positions C-2 and C-7. During the 
biosynthesis of cobalamin and siroheme, the methyl groups are furnished by two SAM 
molecules and the methylation is catalyzed by a family of enzymes known as SAM 
dependent uro'gen III methyltransferases (SUMT). It is a two step reaction with the 
methylations occurring sequentially (Figure 13). The first methylation occurs at C-2 
yielding the intermediate precorrin-1, which is further methylated by a second SAM 
molecule at position C-7. Following each methylation, the SAM molecule gets converted 
to S-adenosyl-L-homocysteine (SAH) and leaves the active site. The methylation takes 
place by a SN2 mechanism (Mascaro et al., 1977) and each methylation is presumed to 
be followed by a prototropic rearrangement of macrocycle double bonds (Stroupe et al., 
2003, Warren et al., 1994).  
 
 
 
Figure 13: SAM-dependent methylation of uro’gen III leading to the formation of precorrin-2. The 
conversion of uro’gen III to precorrin-2 takes place by a two step reaction with the formation of the 
monomethylated intermediate precorrin-1. (Figure adopted from Sonja Storbeck, PhD Thesis, 2011) 
 
Up until now, a number of SUMTs have been discovered from various organisms and 
their roles in the biosynthesis of cobalamin (CobA), siroheme (CysG, SirA, UPM1, 
Met1p) and heme d1 (NirE) have been studied and biochemically characterized. Based 
on their molecular size and enzymatic activity, these SUMTs can be classified into three 
subclasses. The first subclass consists of SUMTs like CobA, SirA, Met1p, and NirE. 
These are monofunctional enzymes exhibiting only SUMT activity. These proteins are 
generally dimeric molecules with each subunit having a molecular weight of roughly 30 
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kDa. The second subclass includes the protein CysG which is also a dimeric protein but 
of higher molecular weight, each of its subunits measuring 50 kDa. The C-terminal 
domain of CysG is homologous to CobA, SirA, Met1p, and NirE and exhibits SUMT 
activity. The N-terminal domain has the dual activity of dehydrogenase-ferrochelatase 
and is responsible for the conversion of precorrin-2 to siroheme via the intermediate 
sirohydrochlorin. Thus, the second subclass consists of a trifunctional member with 
higher molecular weight. The third subclass comprises of fusion proteins, where a SUMT 
belonging to the first subclass, such as CobA, is linked to HemD, giving rise to a protein 
having the dual function of uro’gen III synthase along with SUMT activity.  
Several crystal structures of SUMTs have been solved which include CobA from 
Pseudomonas denitrificans (Vevodova et al., 2004), CysG from Salmonella enterica 
(Stroupe et al., 2003) and the SUMT from Thermus thermophilus (Rehse et al., 2005). 
These structures were solved with the SAH bound to the active site. Based on the 
structural information obtained from these SUMTs, mutational analysis has been 
performed that helped in indentifying the amino acids that are involved in the 
coordination of SAH and SAM. Additionally, on the basis of in silico docking of uro'gen III 
at the enzyme active site, it has been proposed that uro'gen III is bound above SAH. 
Docking also indicated the amino acids that could be involved in the binding of uro'gen III 
and possibly in catalysis. However, due to the lack of an enzyme-substrate structure, 
these speculations could not be verified. In order to gain a complete understanding of 
the reaction mechanism of SUMTs, it is essential to obtain a structure of a SUMT in 
complex with its substrate uro’gen III. This would give a structural insight into the active 
site of the enzyme and also help in identifying the functionally important amino acids. 
The structure of the enzyme-substrate complex would help in reaching a concrete 
conclusion regarding the enzymatic mechanism of SUMTs. This work aims to address 
these questions and understand the detailed mechanism of SUMT enzymes from a 
structural point of view. 
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2. Aims and Scopes 
The central objective of this work was to elucidate the mechanism of the chemical 
reaction catalyzed by the enzymes Cnx1E and NirE. Both the enzymes have been 
implicated in the conserved biosynthetic pathway leading to the synthesis of their 
respective cofactors. A complete understanding of their catalytic mechanism can only 
be reached through the structure of the enzyme-substrate complex of both the 
proteins. 
In order to achieve this goal, both Cnx1E and NirE need to be produced 
recombinant. The recombinant protein was then to be used for obtaining protein 
crystals and for biochemical characterization by functional assays. On obtaining 
single diffracting quality protein crystals, the three dimensional structure of the 
molecule was to be solved by X-ray crystallography. X-ray crystallographic analysis 
would provide a detailed structural insight into the active site of the enzymes. Based 
on the structural information obtained from the enzyme-substrate complex, the 
putative amino acids that could be involved in catalysis were to be identified. In the 
event of the absence of an enzyme-substrate complex as in the case of Cnx1E, the 
substrate was to be modeled into the putative active site to obtain an idea regarding 
the functionally relevant amino acids. Further to this, site directed mutagenesis of the 
identified amino acids was to be performed to obtain the protein variants, which 
should be then subjected to functional characterization by enzyme assays. This 
would enable in identifying the residues involved in substrate coordination as well as 
the catalytically essential residues and ultimately establish the structure-function 
relationship of the protein molecules. Finally, this would provide a conclusive 
understanding of the enzymatic mechanisms of Cnx1E and NirE. 
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3.1. Protein Production 
3.1.1. NirE 
The expression and purification of NirE was done by Sonja Storbeck as a part of her 
Ph.D. thesis. NirE was expressed and purified as described previously (Storbeck et al., 
2009, Storbeck et al., 2011). Briefly, the protein was expressed in E. coli BL21(DE3) 
chemically competent cells. Upon protein expression the cells were harvested and 
resuspended in buffer A [50 mm Tris ⁄ HCl (pH 7.5), 200 mm KCl, 10% (w ⁄ v) glycerol]. 
Cell lysis was performed using a French press at 1000 p.s.i. (68947.57 hPa) and the 
soluble protein was separated from the cell debris by centrifugation for 1 hour at 175 000 
g. The NirE protein contained in the supernatent was purified with a 1.5 mL Ni2+ 
SepharoseTM 6 Fast Flow column equilibrated with buffer A. After applying the protein 
to the column, it was washed several times with buffer A and finally eluted with 2.5 mL of 
buffer A containing 200 mM imidazole. The eluted fractions containing NirE were pooled 
and dithiothreitol (DTT) was added to a final concentration of 5mM. PreScissionTM 
Protease or Tag off enterokinase (Novagen) was added to the NirE solution which was 
dialyzed over night against buffer A. Following dialysis, the tag was removed by applying 
the protein solution to Ni2+-SepharoseTM 6 Fast Flow column. Finally the untagged 
protein was further purified by size exclusion chromatography using a HiLoad 16 ⁄ 60 
Superdex 200 column (GE Healthcare) equilibrated with buffer A. The NirE containing 
fractions were pooled and concentrated by ultrafiltration (Amicon, Millipore GmbH, 
Eschborn, Germany) and subjected to buffer exchange in an anaerobic chamber (Coy 
Laboratories, Grass Lake, MI, USA) against buffer A. Purified NirE was directly used for 
setting up crystallization. 
3.1.2. Cnx1E: 
Cnx1E and its variants were expressed and purified by Corinna Probst as a part of her 
Master’s thesis (Corinna Probst, Master’s thesis 2012). Briefly, the Cnx1E protein was 
expressed as a streptavidin tagged fusion protein in E.coli RK5204 chemically 
competent cells. After protein expression, the cells were harvested by centrifuging at 
17000 g. The cell pellet was lysed using a French press at 1000 p.s.i. the soluble protein 
was separated from cell debris by centrifugation and the supernatant containging Cnx1E 
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was subjected to purification using 3 mL StrepTactin-Matrix (High Cap StrepTactin-
Matrix, IBA). 
3.2 Functional assays 
3.2.1. NirE 
3.2.1.1. Determination of NirE activity 
The determination of the catalytic activity of NirE wildtype and NirE mutants was done in 
an established in vitro activity assay (Strobeck et al., 2009). The activity assay was 
performed under anaerobic conditions in an anaerobic chamber (Coy Laboratories). 1 
mM 5-aminolevulinic was used as the starting compound to synthesize Uro’gen III using 
the enzymes HemB from P. aeruginosa (0.14 µM), HemC (0.15 µM) and HemD (0.17 
µM) both from B. megateriumin in a final volume of 1 mL of thoroughly degassed buffer 
containing 50 mM Tris-HCl pH 8.0, 100 mM KCl, 5 mM MgCl2, 50 mM NaCl, 5 mM DTT. 
The final concentration of NirE wildtype and NirE mutants used was 1.5 µM. For 
quantification purpose, precorrin-2 was converted to sirohydrochlorin by the addition of 
SirC from B. megaterium (1.5 µM) and NAD+ (100 µM). Quantification was done using 
the published extinction coefficient of sirohydrochlorin (ε376nm = 2.4 x 10 5M-1cm-1, 
(Leech et al., 2003)).The reaction was started by adding 200 µM of SAM. The assay 
mixture was incubated at 37 °C in the dark and product formation was monitored using a 
V-550 or V-650 spectrophotometer (Jasco, Groβ-Umstadt, Germany). The determination 
of specific activity of NirE was done using chemically reduced uro’gen III at a final 
concentration of 17 µM. 
 
3.2.1.2. SAM binding assay 
The SAM-binding assay was performed by an already established protocol (Woodcock 
et al., 1996). Purified NirE protein  at a concentration of 100 µM was incubated with 0.5 µ 
Ci of [methyl-14C]-S-adenosyl-l-methionine in a final volume of 250 µL of buffer A at 25 
°C for 1 hour. Following the 1 hour incubation, the protein solution was then passed over 
a NAP-5 column (GE Healthcare) and eluted with 3 mL of buffer A.100 µL fractions of 
were collected and analyzed for radioactivity using a Liquid Scintillation Analyzer Tri-
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Carb 2900TR (PerkinElmer Life Sciences). The binding of SAM was analyzed by 
fluorography (Woodcock et al., 1996). 
3.2.2. Cnx1E 
3.2.2.1. HPLC-based detection of intermediates of the Moco biosynthesis 
Moco and its precursor MPT and MPT-AMP are very unstable and extremely sensitive to 
oxidation. Therefore, they degrade very quickly to their oxidation products FormA and 
FormB, as well as non detectable by-products. These degraded oxidation products 
fluoresce due of their conjugated π-electron system. Hence it is possible to quantitatively 
detect Moco and its precursors by using fluorescence measurement by HPLC (high 
pressure liquid chromatography) on these oxidation products. The formation of only one 
oxidation product (FormA-AMP) is enforced by applying extremely acidic and oxidizing 
conditions, which makes the detection much easier. Quantification of MPT / Moco and 
MPT-AMP is in this work is based on the FormA-peak. The area under this peak 
corresponds to the total amount of FormA and is calculated by integration. The following 
formula is employed to calculate MPT/Moco- or MPT-AMP-saturation: 
 
𝑛(𝑀𝑃𝑇/𝑀𝑜𝑐𝑜) = 𝐴!"#$%  !"  !"#  !"#.!"#"× 𝑡𝑜𝑡𝑎𝑙  𝑣𝑜𝑙𝑢𝑚𝑒𝑎𝑛𝑎𝑙𝑦𝑧𝑒𝑑  𝑣𝑜𝑙𝑢𝑚𝑒  
 
𝑛 𝑀𝑃𝑇 − 𝐴𝑀𝑃 = 𝐴!"#$%  !"  !"#!!"#× 𝑡𝑜𝑡𝑎𝑙  𝑣𝑜𝑙𝑢𝑚𝑒𝑎𝑛𝑎𝑙𝑦𝑧𝑒𝑑  𝑣𝑜𝑙𝑢𝑚𝑒 ×1,6 
 
 
n = Stoffmenge [mol] 
A = Flächeneinheit (Integral des Peaks) 
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3.2.2.2. Oxidation and dephosphorylation of Moco / MPT 
The protein solution to be analyzed (normally 500 pmol protein) was mixed with 0.1M 
Tris-HCl pH 7.2 and made up to a volume of 400 µL and 50 µL fresh oxidation solution 
(1% I2/KI solution and 86 µL 37% HCl) was added.The oxidation was carried out in the 
dark at room temperature overnight. Following the oxidation step, the precipitated 
protein and other deposits are pelleted by centrifugation for 10 minutes at 11000 g. 
The supernatant was transferred to a new tube and mixed with 56 µL of a freshly 
prepared 1% solution of ascorbic acid to reduce the excess iodine. The pH was raised to 
about 8.3 by adding 200 µL of 1M Tris (unbuffered), so that the subsequent alkaline 
phosphatase reaction could be performed. In addition, 13 µL of 1M MgCl2 was added. 2 
µL alkaline phosphatase (AP, 1U/µL) was added to dephosphorylate FormA which 
allows better resolution in HPLC-based FormA analysis. The reaction mix was incubated 
at room temperature at room temperature overnight after which it was treated with AP 
and centrifuged for 10 min at 11000 g and the supernatant is removed. Upon 
dephosphorylation, dephospho-FormA is purified by isocratic anion exchange 
chromatography. 
 
3.2.2.3. Isocratic anion exchange chromatography 
Isocratic anion exchange chromatography enables the purification of the obtained 
dephospho-FormA. For this purpose, a QAE-Sephadex A 25 matrix (Sigma) was used, 
which acts as a strong anion exchanger. The matrix was equilibrated overnight in 1M 
NaCl and 1M ammonium acetate buffer in order to convert it to its acetate form. After the 
equilibration step, 0.5 mL of the matrix material was filled in empty NICK columns and 
sealed by putting a watered frit on top of the matrix which is then used for purification. 
Prior to purification, the matrix is soaked 2 times with 1M ammonium acetate in order to 
remove any residues and convert the matrix completely to its acetate form. The column 
is rinsed twice with filtered distilled water and the centrifuged sample is added to the 
column. After loading the sample, the column is again washed with distilled water to 
remove unbound impurities. The elution of dephospho-FormA is performed using 10 mM 
acetic acid. Initially, a dead volume is added to the column of 300 µL. The bound 
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dephospho-FormA was eluted with 10 mM acetic acid 800µL. The sample is now ready 
for the HPLC analysis, but it can also be stored at -20 ° C.In order to remove the 
dephospho-FormA which is still bound to the column, it was  again washed with 3 mL of 
10 mM acetic acid. The elution of FormA-AMP was done by means of 50 mM HCl. First, 
a volume of 300 µL is added to the column and allowed to sink in. Then, the bound 
FormA-AMP is eluted with 800 µL 50mM HCl. 
 
3.2.2.4. FormA-AMP-determination 
In order to perform the HPLC analysis of the eluted FormA-AMP, it was first converted to 
FormA. 
The FormA-AMP-elution was divided into two aliquots of 350 µL and 25.2 µL. The pH of 
each aliquot was raised to 7.5 by adding 1M Tris (unbuffered). 5.25 µL of MgCl2 (1M) 
and 1 µL phosphodiesterase I (1U/µL) was added to the aliquots to de-adenylate FormA-
AMP. The reaction mix was incubated overnight in the dark at room temperature. In 
order to stop the reaction, the aliquots were incubated for 5 min at 96 °C and then 
incubated on ice for 3 min. The dephosphorylation was carried out in the dark, overnight, 
at room temperature by adding 10.5 µL of 1M Tris (unbuffered) and 2 µL alkaline 
phosphatase (1U/µL). Both aliquots were combined. Then 500 µL of the combined 
sample are analyzed together with 300µL of 10 mM acetic acid by HPLC. 
 
3.2.2 5. HPLC analysis of dephospho-FormA 
The eluates obtained are analyzed by HPLC chromatography on a C18 reverse phase 
column and detected by their fluorescence. The fluorescence detector (G1321A, Agilent) 
of the HPLC pump (G1312A Bin pump, Agilent) was used and was operated with the 
highest sensitivity (gain 16x). The fluorescence of FormA is measured after 370 nm 
excitation and 450 nm emissions. The flow rate was maintained at 1 mL/min. The 
running buffer, a mixture of 5 mM NH4Ac and 15% methanol was chosen. The proportion 
of methanol in isocratic flow determines the retention time of FormA-dephospho. The 
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detected fluorescence was recorded using the Agilent ChemStation software, and the 
area of the FormA-peak was determined. 
3.2.2.6. In-vitro MPT-AMP hydrolysis at Cnx1E-MPT-AMP complex 
The formation of physiologically active Moco by Cnx1E is dependent on divalent cations 
(Llamas et al., 2006). After formation of the Cnx1E-MPT-AMP complex, MPT-AMP 
hydrolysis and the incorporation of molybdenum take place simultaneously to yield 
physiologically active Moco. 
Hydrolysis is induced by adding MgCl2 to 500 pmol of Cnx1E MPT-AMP complex to a 
final concentration of 5 mM. The reaction mix was incubated at room temperature for 20 
minutes. 
The reaction is stopped by the addition of oxidizing solution. Moco and its precursors 
were detected by the same method as HPLC based formA detection. 
 
3.2.2.7. Colorimetric detection of molybdate in biological materials and 
solutions 
For quantitative detection of molybdate in biological materials and solutions a 
photometric method was used. The detection method is based on the formation of a 
green molybdate dithiol complex that is formed by the addition of toluene-3,4-dithiol 
under acidic conditions. This complex can then be extracted and detected 
spectrophotometrically at a wavelength of 680nm. 
The protein solution to be analyzed was made up to a final volume of 100µL with a buffer 
containing 0.1M Tris/HCl pH 8.0, 125mM NaCl and 10% glycerol and denatured by 
heating to 96 °C for 30 minutes. Following this, the mixture was centrifuged for 10 
minutes at 14000 g at room temperature in order to pellet precipitated protein, and the 
supernatant was transferred to a 500µL reaction tube. The complex formation was 
started by adding 200 µL of the dithiol reagent and H2SO4 to a final concentration of 8N 
and incubated for 15 minutes at room temperature. 100 µL isoamylacetate may be 
added to the mixture and vortexed for 1minute to extract the colored complex in the 
organic phase. To speed up the phase separation, the mixture was centrifuged at 8000 g 
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for 10 minute at room temperature. 80 µL of the upper phase was removed and 
measured at 680nm against an isoamylacetate blank. 
3.2.2.8. Calibration line for the determination of molybdate concentration 
A calibration curve is computed by linear regression from the absorption of molybdate 
solutions of different concentrations at 680nm. With help of this curve, the specific 
molybdate saturation of the protein solutions (pmol molybdate/pmol protein) was 
determined.  
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3.3.Crystallographic Methods 
3.3.1. Protein crystallization 
Prior to setting up crystallization trials, purified and concentrated protein was centrifuged 
at 18.800 g for 20 minutes at 4 °C. Initial screening was attempted by sitting drop vapor 
diffusion method using an automated crystallization robot. After obtaining initials hits, 
further optimization was performed manually by hanging drop vapor diffusion method.   
 
3.3.1.1. Crystallization of NirE 
For crystallizing NirE in the absence of its substrate uro’gen III, the enzyme at a 
concentration of 9.2mg/mL was incubated with 2mM SAM for 1 hour prior to use. 
Crystallization trials were done in sitting drop vapor diffusion set ups using an automated 
Mosquito crystallization robot TTP Lab Tech Ltd., Melbourne, UK). For the crystallization 
drops, 200nL of NirE solution was mixed with 200 nL of buffer solution from JCSG I-IV 
and ammonium sulfate screens (Qiagen, Hilden, Germany). Crystals grew within 3-6 
days and were soaked with 20 % glycerol prior to shock cooling in liquid nitrogen.  
 
For crystallization of NirE along with its substrate uro’gen III the protein was used at a 
concentration of 10 mg/mL. Uro’gen III was obtained by reducing uroporphyrin III by 
chemical reduction using H2/palladium as previously described (Layer et al., 2002). 
Crystallization was set up in an anaerobic chamber at 17 °C by sitting drop vapor 
diffusion method. Prior to crystallization, the protein was incubated with an 82-fold molar 
excess of uro’gen III and 1 mM SAH for a period of 1 hour. 1 µL of protein solution was 
mixed with 1 µL of reservoir solution of the JCSG+ Screen (Qiagen, Hilden, Germany) 
and incubated in the dark. Crystals grew within 4-8 days. 
 
3.3.1.2. Crystallization of Cnx1E 
Initial screening 
Initial crystallization trials were done with commercially available screens from Qiagen 
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(see Chapter 3.1.3) in 96-well sitting drop vapor diffusion plate (Greiner). 200nL of pure 
protein at a concentration of 10mg/mL was mixed with an equal volume of reservoir 
solution from the commercial screens using the Honeybee 961 crystallization robot 
(Zinsser Analytics). The plates were sealed using a MancoTM Crystal Clear tape (Jena 
Bioscience) and incubated at 18 °C which facilitated the equilibration of the drops 
against the reservoir solution. The plates were checked at an interval of 3 days for the 
appearance of crystals with a microscope. 
Optimization 
Initial crystals obtained from the 96 well plates were tested for possible diffraction and 
further optimized in using 24 well hanging drop vapor diffusion plates. The main 
parameters that were varied for optimization were protein and precipitant concentrations 
and pH of the buffer. The drop size was also increased to 4 µL. Crystallization was set 
up using 2 µL of protein mixed with an equal volume of reservoir solution. Additionally, 
seeding techniques like streak, micro and micro-seeding (Bergfors, 2003; Luft & DeTitta, 
1997), Additive Screen (Hampton Research) were also tried to obtain larger crystals with 
better diffraction properties. 
 
3.3.2. Cryo protection 
Protein crystals upon irradiation by x-rays result in the generation of free radicals within 
them. These radicals can migrate through the crystals and damage them, thereby 
resulting in rapid loss of diffraction. To reduce this damage, crystals can be subjected to 
shock freezing to 100K in liquid nitrogen. However, aqueous solutions on being frozen 
can lead to the formation of ice which also have the potential to damage the crystal and 
compromises the quality of the measured data due to its own diffraction (ice rings). In 
order to overcome this problem, cryo protectants such as small molecular weight PEG, 
glycerol or sugars can be added. Cryo protectants were prepared by mixing 10 – 20 % of 
glycerol to reservoir buffer. Crystals were removed from the crystallization drop by a 
nylon loop to this solution of cryo protectant. Following this the crystals were quickly 
frozen in liquid nitrogen. 
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3.3.3. Data collection 
The crystals used for data collection were shock frozen in liquid nitrogen and were 
maintained at 100 K by a continuous stream of cold nitrogen gas. Crystals were 
screened in house using a Rigaku MicroMax 007HF rotating anode x-ray generator 
rotating anode x-ray generator at a wave length of 1.54 Å with a Saturn Image plate 
detector. Complete data sets for NirE crystals were collected at the beam lines of 
Berliner Synchrotron Gesellschaft m.b.H (BESSY) in Berlin, Germany with a Raynonix 
MX225 3x3 CCD detector (Marresearch GmbH Norderstedt, Germany) at a wave length 
of 0.9537Å. For the Cnx1E crystals, the data collection was done in house using the 
same x-ray source and detector as used for screening.  
Collection of diffraction data was done by the oscillation method which implies the 
rotation of the crystal in small oscillation steps (Ф) around an axis perpendicular to the 
incident x-ray beam. Crystal mosaicity and cell parameters are the main determinants on 
which determines the optimal oscillation range for each image; for the experiments 
carried out in this investigation, the typical value was 0.8°.  As a result of each 
oscillation, a diffraction image was generated which exhibited a pattern of strong 
reflections (i.e. BRAGG peaks). The intensities of these peaks and their spatial 
arrangement reflects the electron density function ρ(x,y,z) of the crystal. BRAGG peaks 
emerge as a result of the elastic scattering of incident beams by the atoms in the crystal 
and the constructive interference of these scattered waves, which takes place when their 
phase shift is a multiple of 2π. This condition can be expressed by the BRAGG equation. 
                                                            𝑛𝜆   = 2𝑑   sin 𝜃 
The EWALD sphere can be used to illustrate the implications of the equation-1. The 
EWALD sphere is a geometric construct in the reciprocal space whose radius is equal to 
λ-1. A crystal can be regarded as a lattice of points of equal symmetry defined by its 
primitive vectors a, b, c. A related reciprocal lattice with the respective vectors a*, b*, c* 
can be generated in reciprocal space. The oscillation in real space corresponds to a 
rotation of the reciprocal lattice through the EWALD sphere. The BRAGG diffraction 
condition as expressed in equation-1 is satisfied when the surface of the EWALD sphere 
intersects a grid point of reciprocal lattice and these results in an emerging beam which 
generates a reflection on the surface of the detector. For collecting a complete data set, 
(equation - 1) 
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crystallographic data needs to be collected over an angular range which is dependent on 
the orientation of the crystal as well as its inherent symmetry.  
In this investigation, XDS (Kabsch 2010) and HKL suite (Minor et al., 2002) was used to 
determine the crystal parameters, assign space group, index and integrate the images’ 
reflections. The scaling of intensities and the merging of partial reflections were done 
with SCALA (Evans, 2006) of the CCP4 suite (CCP4, 1994) and converted to structure 
factor amplitudes with TRUNCATE. The Rsym value which can be calculated for the 
resolution shells, determines the quality of a data set. It shows how well intensities of the 
symmetry related reflections hkl are correlated. The Rsym is calculated by the following 
formula: 
𝑅!"#   𝐼   =       !!   !!" !  !  (!!")     !  !!"      !!   !!"       !  !!"  
Where I (hkl) is the average intensity and Ii (hkl) is the scaled intensity of the 
observations of a given reflection. A high Rsym must be avoided by scaling the data set to 
a lower high resolution limit. Another quality control criteria which was monitored was the 
value of I/σ(I). When the value of I/σ (I) was less than 2 scaling of the data was repeated 
with a lower high-resolution limit as it was considered to be an extremely low signal-to-
noise ratio. Finally the completeness of the data set is calculated by the following 
formula: 
𝐶 =    !obs  !theo   
nobs is the number of observed reflections and ntheo is the number of theoretically 
observable reflections for the resolution shells. When the completeness in a shell is less 
than 0.95, it  indicates a lack of data for this resolution range which can be either 
avoided by scaling to a tighter resolution limit (in case the highest resolution shell in 
incomplete) or by increasing the total angular range of the data collection.  
(equation - 2) 
(equation - 3) 
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3.3.4. Phasing by Molecular Replacement 
Similar to all electromagnetic waves, the three parameters frequency, amplitude and 
phase characterize an x-ray scattered by the atoms of a crystal. The intensity and the 
position of the BRAGG peaks determine the amplitude and frequency of the emerging x-
ray respectively. However, the phase is un detectable and unavailable for calculating the 
electron distribution ρ(x,y,z). The FOURIER transform of the crystal’s electron 
distribution ρ(x,y,z) is the structure factor F(hkl) and vice versa. The structure factor can 
be expressed as a function of hkl:  
 
𝐹   ℎ𝑘𝑙 = 𝑉 𝜌   𝑥𝑦𝑧   𝑒!!"   !!!!"!!"   𝑑𝑥  𝑑𝑦  𝑑𝑧!!  
 
According to the BRAGG equation, diffraction occurs only in discrete directions. Hence 
for calculating the electron distribution function, a summation of individual structure 
factors can be used to replace the integration:  
𝜌   𝑥𝑦𝑧   = !!             !     ! 𝐹   ℎ𝑘𝑙   𝑒!!!"  (!!!!"!!")  !  
 
The structure factor being a vectorial quantity can be expressed as the complex number: 
  𝐹!!"   = |𝐹!!"|  𝑒!!!!" 
 
Where α is its phase and |Fhkl| is the magnitude of the structure factor. The direct 
determination of structure factors and thereby the electron density becomes impossible 
due the lack of phase information in the crystallographic data. However, the amplitude of 
the structure factor can be determined from the intensity as they are proportional to each 
other (equation 7). 
𝐼!!"   ~  |𝐹!!"|! 
(equation - 4) 
(equation - 5) 
(equation - 6) 
(equation - 7) 
MATERIALS AND METHODS 
 
 45 
In this study, molecular replacement was used to solve the phase problem. Molecular 
replacement is a crystallographic approach of phase determination by using the already 
solved structure of a structurally homologous protein which serves as the starting point 
of refinement. The structures of two homologous proteins are likely to be similar and 
they show a certain degree of sequence identity. The problem of molecular replacement 
is to transfer and orientation of the known protein structure (also known as search 
model) in the new unit cell. These two molecules can be superimposed onto each other 
by applying rotational and translational movements. The translation is usually described 
by a set of distance coordinates whereas the rotation is described by a set of EULERian 
or polar angles.  
Finding these two sets of coordinates presents a six dimensional problem which can be 
split into two independent searches, first the correct rotation search followed by the 
search for correct translation. To do so, a PATTERSON map is calculated from both the 
search model and the experimental data. The PATTERSON map is a vector map 
representing inter-atomic distances as vectors from an origin. From the experimental 
data it can be calculated without the knowledge of the phases as: 
𝑃   𝑢𝑣𝑤 =    !!        !!" |𝐹   ℎ𝑘𝑙 |! cos    2𝜋   ℎ𝑢 +   𝑘𝑣 + 𝑙𝑤  
 
The coefficients in equation 8, in contrast to the coefficients in equation 5, are only 
structure factor amplitudes and not structure factors. A rotation of the PATTERSON map 
results in the same rotation of the real structure and vice versa. A rotation of a 
PATTERSON map of the search model (resulting Pr (ur)) and an overlap function of the 
PATTERSON maps from the search model and the data set is calculated as:  
 𝑅   𝛼𝛽𝛾 =      𝑃   𝒖 ×  𝑃!    𝒖! 𝑑𝒖    !  
 
Where U is the volume of the Patterson map where the self-Patterson peaks (i.e. the 
peaks from intra-molecular vectors) are located. The product function R will be maximum 
(equation - 8) 
(equation - 9) 
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for the correct orientation and is dependent on the rotation angles α, β, γ. The rotation 
function can be determined by conducting a search for the maximum overlap of the two 
Patterson maps of the search model and the unknown structure. Rossmann and Blow 
were the first to present the mathematical algorithm in 1962 to solve the rotation 
function. However, nowadays the most commonly used rotation function is the one 
introduced by Cowther in 1972 which is much faster.  
After finding the correct rotation function, the correct position of the search model in the 
asymmetric unit needs to be determined. This is also done in the Patterson space by 
maximizing R of equation 9 but this time using inter-molecular vectors. In this case, R is 
dependent on translational vectors and not on angles. If the search model only partially 
forms the contents of the asymmetric unit, - e.g. if the search model exists as a 
monomer whereas the protein being studied is a dimer – then the rotation function is 
expected to have several solutions. A translation function needs to be calculated for 
each solution of the rotation function. In this investigation, MOLREP (Murshudov et al., 
1997) was used to carry out molecular replacement. 
 
3.3.5. Model building and Refinement 
The observed intensities and model phases were used to calculate an initial electron 
density (equation 5). However, due to the disagreements between the search model and 
the structure, this initial electron density harbored many errors and was probably 
affected by model bias as well. The first coordinates were checked and adjusted against 
2Fo-Fc and Fo-Fc maps in COOT (Emsley et al., 2010) and improved by manually 
rebuilding refining in REFMAC (Murshudov et al., 1997). Calculation of R-factor  
𝑅   =        !!" !!"# !  !   !!"#!!!"#     !!"  
 
was used to monitor the agreement of observed and calculated structure factors. Rfree 
was used to observe the progress of the refinement. It is calculated as the conventional 
R-factor but uses 5% of the observed reflections which were excluded from refinement. 
Refinement was continued till the R-factors converged. 
(equation - 10) 
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3.3.6. Bioinformatics and tools: 
Theoretical data about the protein constructs such as extinction coefficients were 
calculated using the Protparam tool (Gasteiger et al. 2003). ClustalW (Larkin et al. 2007) 
as incorporated in the T-coffee server (Notredame 2010) was employed to generate 
multiple sequence alignments and figures of these alignments were produced with 
ESpript (Gouet  et al. 1999). Pymol was used to generate the figures of the protein 
models. All protein models were deposited in the Protein databank (PDB) (Berman et al. 
2000).
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4. Results 
 
4A. Role of Cnx1E in the synthesis of molybdenum cofactor 
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4A.1. Protein production 
Expression clones of Cnx1E were kindly provided by Dr. Tobias Kruse (TU-
Braunschweig). The protein was expressed as C-terminal strep-tag II fusion protein in E. 
coli RK5204. The cells were grown in LB media and protein expression was induced by 
IPTG (Figure 14A). After cell lysis, the recombinant protein was purified by StrepTactin 
affinity chromatography. The protein was not subjected to any further purification since it 
was reasonably pure after the single step purification as seen from the SDS-PAGE 
analysis (Figure 14B).  
 
 
 
Figure 14: Purification of wildtype Cnx1E. (A) Chromatogram of StrepTactin affinity purification. (B) SDS-
PAGE analysis of the peak fractions. E1-E5 are the eluted fractions corresponding to the major peak marked 
as Cnx1E. 
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4A.2. Crystallization 
Crystallization of Cnx1E was first attempted with the robot by sitting-drop vapor-diffusion 
method under oxic conditions. The protein readily crystallized in various conditions of the 
JCSG core IV screen. Best crystals were seen in 50 mM Li2SO4, 0.1 M Hepes pH 7.5, 
30% (v/v) PEG 600, 10% (v/v) Glycerol (JCSG-D11)(Figure 15A). Initial crystals from the 
screen appeared within 48 hours. However, these crystals were too small and showed 
very weak diffraction. Hence, the crystals were further optimized manually by hanging-
drop vapor- diffusion method. The parameters which were mainly altered were the 
protein and precipitant (PEG 600) concentrations as well as the pH of the buffer 
(Hepes). Better crystals were observed in the hanging drop plates in 3-6 days. The 
protein had a tendency to form better crystals at a concentration of 4 mg/mL and at a pH 
4-5 with lower precipitant concentrations. The optimization resulted in much bigger 
crystals (about 40µ) in the condition, 50 mM Li2SO4, 0.1 M Hepes pH 4.5, 15% (v/v) PEG 
600, 10% (v/v) Glycerol (Figure 15B). All crystals were transferred into cryo-solution 
containing reservoir buffer with 16 % (v/v) glycerol as cryo-protectant and flash-cooled at 
100 K in liquid nitrogen. 
 
  
Figure 15: Crystals of Cnx1E. (A) Initial crystals of Cnx1E obtained in the D11 condition of the JCSG core 
IV screen in the 96 well sitting-drop set-up. (B) Manually optimized crystals of Cnx1E obtained in the 24 well 
hanging-drop set-up. 
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4A.3. Data Collection, phasing, refinement and validation 
The dataset for Cnx1E crystal was collected in house at a Rigaku MicroMax 007HF 
rotating anode X-ray generator. The crystal belonged to the space group I222 and 
datasets up to 2.6 Å resolution were collected. The datasets were processed with XDS 
(Kabsch, 2010) and scaled with SCALA (Evans, 2006) as included in the CCP4 suite 
(CCP4, 1994).  The Mathews coefficient (Mathews, 1968) was determined to VM = 2.8 Å3 
Da-1, which indicated the presence of only one Cnx1E molecule in the asymmetric unit. 
MOLREP (Murshudov et al., 1997) was used to perform molecular replacement using 
the monomer of MoeA (PDB ID-1FC5) (Schrag et al., 2001) as the search model. The 
solution obtained by MOLREP was manually corrected and rebuilt in COOT (Emsley et 
al., 2010). Following this, the model was refined using REFMAC5 through rigid body and 
restrained refinement (Murshudov et al., 1997). After several rounds of refinement Rwork 
and Rfree finally converged to 26.6% and 29.3%, respectively. Table 1 summarizes the 
data collection and refinement statistics.  Validation of the final models was done using 
MOLPROBITY (Davis et al., 2007). All the residues for every model fall into the allowed 
region of the Ramachandran plot (Ramachandran & Sasisekharan, 1968). 
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Table 1: Crystallographic data and refinement statistics 
. 
Data collection  
Beamline Rigaku MircoMax 007HF 
Wavelength (Å) 1.541 
Resolution (Å)a 30.92 -- 2.6 (2.693-2.6) 
Space group I222 
 
Unit cell parameters 
 
a,b,c (Å) 66.18, 124.03, 131.07 
α,β,γ (°) 90, 90, 90 
Unique reflectionsa 16,123 (1559) 
Multiplicitya 3.8 (3.9) 
Completeness (%)a 98.4 (97.2) 
I/σIa 20.18(2.57) 
Rmerge a,b 0.075 (0.504) 
Wilson B (Å2) 41.04 
Solvent content (%) 46.4 
 
 
Refinement 
 
Rworkc 0.2664 
Rfreed 0.2931 
No. of atoms  
Protein 3115 
Water 131 
Total 3246 
  
r.m.s.d from ideal  
Bond lengths (Å) 0.013 
Bond angle (°) 1.67 
Ramachandran plot  
Favored (%) 96.1 
Allowed (%) 2.2 
Disallowed (%) 0.0 
 
 a Values in parentheses account for the highest resolution shell. 
 b Rmerge = Σ|Io - 〈I〉| / ΣIo 
 c Rwork = (Σ||Fo|-|Fc||/Σ|Fo|); |Fo|: structure factors magnitudes observed; |Fc|: structure factors calculated. 
 d Rfree calculates as Rwork but from 5% randomly selected reflections that are excluded from refinement 
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4A.4. Overall structure of Cnx1E monomer  
The Cnx1E monomer composed of 460 amino acid residues, adopts an extended 'L' 
shape consisting of four well separated sub-domains (Figure 16A, B). The long arm of 
the letter 'L' comprises of sub-domains 1 and 2, while sub-domain 4 forms the base. 
Sub-domain 3 is at the corner of the two arms. The overall structure of the monomer is 
shown in Figure 16A. From the crystal structure of Cnx1E it is seen that sub-domain 3 is 
the largest of the four whereas the smallest of them is sub-domain 1 which is also 
involved in bridging the sub-domains 2 and 3. The extended ‘L’ shape of the monomer 
also aids in its dimerization. This is discussed later. 
From the primary structure of the protein it is seen that sub-domains 1 and 3 are formed 
of discontiguous amino acid residues. The N-terminal end of the polypeptide chain folds 
into an α-helix, forming a part of the sub-domain 3, and continues further to form half of 
sub-domain 1 and the complete sub-domain 2. After folding into sub-domain 2, the chain 
extends to form the remaining half of sub-domain 1, followed by the major portion of sub-
domain 3 and concludes in sub-domain 4. As a result of this discontiguity, there are two 
linkers involved in joining sub-domains 1 and 2, as well as sub-domains 1 and 3, 
whereas sub-domain 4 is connected to sub-domain 3 by a single linker. 
The overall structure of Cnx1E shows that the number of β-strands outnumbers the 
number of α-helices by a ratio of 1:2 and almost one third of the molecule is comprised 
of flexible loops (Figure 16A). While sub-domain 3 has almost an equal number of 
helices as β-strands, the remaining sub-domains predominantly consist of β-strands. In 
the figures of the protein molecule, the helices are represented by letters whereas the β-
strands are denoted by numbers. The same form of representation is used for all the 
structures in this work. The structure of each of the four sub-domains is described below 
in detail. 
 
  54 
 
 
 
Figure 16: Structure of Cnx1E. (A) Monomer of Cnx1E (content of the asymmetric unit) in cartoon representation. The four separate sub-domains are 
differentiated by different colors. (Sub-domain 1– red, sub-domain 2- blue, sub-domain 3-green and sub-domain4- yellow) The same color code has been used to 
represent these domains in all the structures of Cnx1E depicted in this work. The helices are represented by letters whereas the β-strands are denoted by 
numbers.  (B) Topology diagram of Cnx1E. Helices are depicted as cylinders and β-strands as arrows. The individual domains are colored according to figure 16A.
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I 
I 
III 
II 
IV 
RESULTS 
 55 
Sub-domain 1 (Figure 17A), the smallest of the sub-domains, consists of two 
polypeptide segments, composed of 20 and 29 amino acid residues (35-55 and 159-
188) running anti-parallel to each other. In the amino acid sequence, these two 
segments are separated from each other by 85 residues that make up sub-domain 2.  
The sub-domain is composed of four β-strands and two α-helices. This kind of two-
stranded β-structure with hydrogen bonding pattern similar to β-sheets are generally 
referred to as β-ladders. From the overall quaternary structure of this domain, it 
appears that the two polypeptide chains fold into a loop consisting of a right handed 
spiral. This spiral starts with a β-ladder composed of β-1 and β-9, followed by two 
short α-helices, B and D, and ends with the second β-ladder of β-2 and β-8 extending 
towards sub-domain 2.  
 
The edge of the long arm of the ‘L’ shaped molecule is occupied by sub-domain 2 
(Figure 17B). Unlike sub-domain 1, it is formed of contiguous amino acid residues 
(residues 58-153). This segment is mainly made up of five β-strands. Two of them 
form a β-ladder (β-4 and β-7) and the remaining 3 strands form a central mixed β-
sheet (β-3, β-5 and β-6). Another characteristic feature of this sub-domain is the 
presence of a considerable amount of loops. 
Sub-domain 3 (Figure 17C), the largest of the four sub-domains, has a compact 
globular α/β/α structure. Residues 14-32 from the N-terminal end, which forms an α-
helix, pack with residues 189-349 to complete this sub-domain. It is characterized by 
a central mixed β-sheet composed of 6 β-strands. The two faces of this β-sheet are 
occupied by four α-helices, two on each side. The four α-helices are formed from the 
contiguous segment of the amino acid sequence and pack almost parallel to the 
central β-strands. The α-helix A at the N-terminal end of the monomer, predominantly 
consists of polar amino acids and is exposed to the solvent. It is located alongside 
the α-helices E and H. It was further observed that the structure of sub-domain 3 is 
highly similar to Cnx1G. This is discussed in detail in the next section. 
The short arm of the ‘L’ shaped monomer is formed by sub-domain 4 (Figure 17D) 
and is located at the C-terminal end of the molecule. This domain is predominantly 
composed of five β-strands along with a 310 helix. The characteristic feature of this 
domain is the β-barrel formed by twisting of the five β-strands. The longest among 
these five strands is the strand β-17 whose two ends (N and C terminus) interact with 
two different β-strands (β-18 and β-19). Its C-terminal end is involved in the formation 
of a β-hairpin along with the strand β-18 while its N-terminal end packs along the β-
RESULTS 
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strand β-19. The strands β-18 and β-19 are connected to each other by a long loop 
that harbors a short and the only α-helix I of the domain. Two loops, one between β-
16 and β-17 and the other between β-19 and β-20, running in anti-parallel direction 
form a cap at one end of this β-barrel. This extended conformation of two loops is 
reminiscent of antiparallel β-strands, however they lack extensive hydrogen bonds. 
 
 
 
 
Figure 17: Cartoon representation of the four individual sub-domains of Cnx1E. (A) Sub-domain 1, 
(B) sub-domain 2, (C) sub-domain 3 and (D) sub-domain 4. The helices and β-strands are numbered 
according to Fig 12 A,B.  
 
 
The crystal structure of Cnx1E revealed that the molecule exists as a homodimer 
(Figure 18). The extended shape of the molecule facilitates all four sub-domains of 
the monomer to indulge in extensive contacts with the other monomer for the 
A B 
C D 
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dimerization. The monomers mainly exhibit van der Waals contacts. On closer 
observation of the molecular surface, numerous grooves, clefts and depressions are 
seen that aid in the interactions between the two monomers (Figure 18).  From the 
crystal structure, it is seen that the sub-domains 1 and 2 of one monomer extend 
along the groove formed at the interface between the sub-domains 3 and 4 of the 
other monomer. Sub-domain 2, compared to the other three sub-domains, 
demonstrates least participation in intermolecular interaction and flanks from the two 
ends of the dimer.  
 
 
 
Fig 18:  Stereo view of the homodimeric assembly of Cnx1E. One of the monomers of the dimeric 
molecule is shown in cartoon representation whereas for the other monomer, its surface is depicted. 
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4A.5. Structural comparison of Cnx1G with the domain 3 of Cnx1E 
The structure of Cnx1G monomer is highly similar to the sub-domain 3 of Cnx1E, as 
indicated by root mean square distance (rmsd) of Cα positions of 1.16 Å, calculated 
with PYMOL. Both are compact globular structures exhibiting α/β/α architecture and 
are characterized by a central mixed β-sheet surrounded by α-helices. On comparing 
the topology (Figure 19A, B) of the two structures, it is observed that the central β-
sheet of Cnx1E sub-domain 3 is composed of six β-strands, five of which are parallel 
and one is anti parallel, whereas in Cnx1G the central β-sheet is five stranded, of 
which four strands are parallel and one strand is anti-parallel. The β-strand missing in 
Cnx1G is β-13. In both the structures, the α-helices pack almost parallel on either 
side of the central β-sheet. In Cnx1E, two α-helices occupy one face of the central β-
sheet, whereas the other face is occupied by three helices. On comparing the 
arrangement of helices in Cnx1G with the structure of sub-domain 3 of Cnx1E, it is 
seen that the latter has one helix less. The extra helix in Cnx1G is a 310 helix (X), and 
is the only helix in the structure that is not parallel to the central β-sheet.   
The presence of one extra β-strand and the absence of one α-helix in Cnx1E 
become clearer on superimposing Cnx1G on the sub-domain 3 of Cnx1E. Figures 
19C and D show two opposite face views of the superimposition of Cnx1G on the 
sub-domain 3 of Cnx1E.  The region of the polypeptide chain forming the extra β-
strand, β-13 and the loop joining β-13 to β-14 in Cnx1E, folds into a long α-helix (Y) 
in Cnx1G. Another difference between the two structures is observed in respect to 
the β-strand, β-11 in Cnx1E, which is much shorter than its counterpart in Cnx1G. In 
the superimposed structure, it is seen that most of the β-strands and α-helices of 
Cnx1G coincide with their structural counterparts in sub-domain 3 of Cnx1E. Only the 
bent α-helix (Y) and the 310 helix (X) of Cnx1G do not have a structural equivalent. In 
Cnx1E, the additional β-strand, β-13, and the α-helix, A, do not have a structural 
equivalent in Cnx1G.  
A sequence alignment of Cnx1G with sub-domain 3 of Cnx1E was done using 
CLUSTALW (Larkin et al., 2007) and it revealed the identical amino acids in the two 
structures (Figure 20). The figure shows a sequence based alignment of secondary 
structure elements where it is clearly seen that the segment of the amino acid 
sequence involved in forming the extra β-strand, β-13 in Cnx1E, forms the α-helix Y 
in Cnx1G. The alignment also shows a significant size difference of the β-strand β-11 
in both structures . 
A B 
RESULTS 
 59 
 
 
 
  
 
 
 
Figure19: Comparison of Cnx1E sub-domain 3 (green) with Cnx1G (brown). (A, B) Topology 
diagrams of Cnx1E sub-domain 3 (A) and Cnx1G (B). (C, D) Two opposite faces of superimposed 
Cnx1G (brown) on the domain 3 of Cnx1E in cartoon representation. 
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Figure 20: Structure based sequence alignment of sub-domain 3 of Cnx1E with Cnx1G. The 
secondary structure elements of Cnx1E are shown in green whereas for Cnx1G are shown in brown. 
Helices are depicted by cylinders and the β-strands are shown by arrows. The identical amino acids in 
the two sequence are highlighted by a red box. 
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4A.6. Functional characterization of residues implicated in catalysis and 
substrate binding 
Previous studies had identified the residue Asp-274 as an important residue involved 
in catalysis and Gly-108 was implicated in substrate binding (Corinna Probst, 
Master’s Thesis, 2012). With the aim of functional characterization of these two 
residues, four mutants were designed: Cnx1E-S269DD274S, Cnx1E-D274R, Cnx1E-
G108DS269DD274S and Cnx1E- G108DD274R. These four mutants had the 
common goal of trapping the substrate MPT-AMP in the active site due to their 
compromised catalytic activity. Hence, from now on, they are referred as putative 
MPT-AMP hydrolysis mutants. The exchange of the aspartate and serine residues in 
the double mutant Cnx1E-S269DD274S was designed with the objective of knocking 
out the function of the catalytically important aspartate (Asp-274), and at the same 
time, making it less conservative than the Cnx1E-D274R mutant. Previously, it had 
been observed that the Cnx1E-G108D mutation resulted in the high saturation of the 
substrate in the enzyme (Corinna Probst, Master’s Thesis, 2012). Hence, this 
mutation was introduced in the previous two mutants with the aim of increasing the 
substrate saturation in the active site of the enzyme. The mutants were expressed as 
C-terminal Strep-tag II fusion protein in E. coli SE1581 and purified by StrepTactin 
affinity chromatography. Figure 21 shows the SDS-PAGE analysis of the four 
mutants. The mutants were created by Dr. Tobias Kruse. 
 
Figure 21: SDS-PAGE analysis of the four Cnx1E variants. (Figure taken from the master’s thesis 
Corinna Probst, 2012).  
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4A.6.1. Analysis of MPT-AMP saturation in the putative MPT-AMP 
hydrolysis mutants 
The mutants were analyzed for the presence of bound MPT-AMP and MPT/Moco co-
purified from E. coli. The quantification of Moco/MPT-AMP can be performed only on 
its stable oxidation product FormA. Figure 22 shows the calculated peak areas of 
FormA per pmol of Cnx1E mutants determined by an established HPLC analysis 
(Corinna Probst, Master’s Thesis, 2012). This experiment was performed by Corinna 
Probst as a part of her master’s thesis. 
 
 
 
 
Figure 22: MPT/Moco and MPT-AMP content of the putative MPT-AMP hydrolysis mutants and 
the Cnx1E wild-type protein. The histograms represent MPT/Moco and MPT-AMP content in FormA 
peak area per pmol of protein Cnx1E-S269DD274S, Cnx1E-D274R, Cnx1E-G108DS269DD274S, 
Cnx1E-G108DD274R. The standard deviations were calculated from the results of three independent 
FormA analyzes. (Figure modified from Corinna Probst, Master’s Thesis, 2012) 
  
 
 
The Cnx1E wild-type protein was used as a reference. From the Figure 22, it is seen 
that the mutants Cnx1E-S269DD274S and Cnx1E-D274R, have comparable 
amounts of MPT-AMP bound to them. It is further observed that, on introducing the 
additional G108D mutation to Cnx1E-S269DD274S and Cnx1E-D274R, have only 
half as much MPT-AMP was bound to them.  Very small amounts of the product 
MPT/Moco was observed to be present in the mutants when compared to the wild-
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type protein with Cnx1E-G108DD274R showing no detectable amounts of MPT-AMP 
by HPLC analysis. The expression, purification and biochemical analysis of bound 
MPT-AMP and MPT/Moco was done by Corinna Probst as a part of her master’s 
thesis. 
 
4A.6.2. Colorimetric detection of protein bound to the putative 
molybdate Cnx1E MPT-AMP hydrolysis mutants and ICP-MS analysis 
Molybdate is the source of molybdenum for insertion into Moco. Previous research 
has shown that that MPT-AMP and molybdate bind cooperatively to Cnx1E (Llamas 
et al., 2007). Based on this observation, the determination of molybdate saturation in 
Cnx1E can be directly related to the MPT-AMP saturation of the enzyme. The 
molybdate saturation in Cnx1E was detected using a colorimetric detection method 
by Corinna Probst as a part of master’s thesis. Figure 23 shows the Molybdate 
saturation in the four putative MPT-AMP hydrolysis mutants. 
 
 
 
 
Figure 23: The Molybdate saturation in the four putative Cnx1E mutants. (Figure modified from 
Corinna Probst, Master’s Thesis, 2012) 
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Molybdate was detected in all the four mutants. The highest molybdate saturation of 
about 7% was observed in Cnx1E-D274R mutant, followed by Cnx1E-S269DD274S 
showing about 6% saturation. The mutants with the additional G108D mutation, 
Cnx1E-G108DS269DD274S and Cnx1E-G108DD274R, demonstrated a low 
molybdate saturation of about 2%. 
 
4A.6.3. In vitro MPT-AMP hydrolysis 
It has already been established that Cnx1E can catalyze the hydrolysis of MPT-AMP 
in the presence of divalent cations followed by insertion of molybdenum to yield 
Moco (Llamas et al., 2007). A HPLC based in vitro MPT-AMP hydrolysis assay was 
designed to determine whether the MPT-AMP hydrolysis mutants’ catalytic activity 
was impaired. The in vitro MPT-AMP hydrolysis assay was performed by Corinna 
Probst as a part of her master’s thesis. Figure 24 shows the MPT-AMP content of the 
four putative MPT-AMP hydrolysis and mutants before and after MgCl2 incubation. 
As a positive control, Cnx1E-G108D co-purified with MPT-AMP was used.  
 
 
Figure 24: In vitro MPT-AMP hydrolysis assay of the putative MPT-AMP hydrolysis mutants. The 
figure shows the MPT-AMP (FormA peak area per pmol protein) of the four putative MPT-AMP 
hydrolysis mutants along with the mutant Cnx1E G108D as the positive control before and after MgCl2 
incubation. (Figure modified from Corinna Probst, Master’s Thesis, 2012) 
 
The comparison of the detectable MPT-AMP strength (Figure 24) before and after 
addition of MgCl2 shows that the MPT-AMP composition in the mutants is not 
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changed at all in the four putative MPT-AMP hydrolysis mutants. However, it was 
observed that in the case of Cnx1E-G108D mutant which was used a positive 
control, no MPT-AMP could be detected after 30 minutes. Thus the four mutants 
cannot process MPT-AMP to Moco efficiently, which confirmed the role of Asp-274 in 
catalysis and the role of Gly-108 in substrate coordination. 
 
RESULTS 
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4B. Role of NirE in the synthesis of the tetrapyrrole heme d1 
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4B.1. Crystallization 
Crystallization trials of purified recombinant NirE from Pseudomonas Aeruginosa were 
attempted in the presence of SAM that had been added to the crystallization set-up. 
SAM had a conducive effect on the growth of NirE crystals as crystallization attempts 
without SAM resulted in the growth of poor quality crystals. Although SAM was added to 
the crystallization set-up, it was converted to SAH by the enzyme. NirE readily 
crystallized in various conditions. The best crystals grew in Tris pH 8.0, 24 % PEG 6000 
(Figure 28A) within 3-6 days. Co-crystallization of NirE along with its substrate uro'gen III 
and the reaction by-product SAH was also attempted by sitting-drop vapor-diffusion 
method. However, in this case, the crystallization was done under anoxic conditions due 
to the high oxygen sensitivity of uro'gen III. The reaction by-product SAH was included in 
the crystallization set-up instead of SAM, in order to trap uro'gen III in the active site and 
prevent its methylation by the enzyme. Similar to the previous crystallization trials, the 
NirE-SAH-uro’gen III complex crystallized in several conditions in a time span of 4-8 
days. The best crystals grew in 0.2 M Li2SO4, 0.1 M Tris pH 8.5, 1.26 M 
(NH4)2SO4(Figure 28B). The crystals of NirE-SAH, as well as those of NirE-SAH-uro'gen 
III were base-centered orthorhombic. Apart from a few variations in their unit cell 
dimensions, both the crystals were isomorphous (for details, see table 2). Crystallization 
of NirE-SAH and NirE-SAH-uro’gen III complex was done by Sonja Storbeck as a part of 
her Ph.D. thesis (Sonja Storbeck, Ph.D. Thesis, 2011). 
 
 
 
Figure 28: Crystals of NirE. (A) Crystal of NirE + SAM. (B) Crystals of NirE+SAH+Uro'gen III 
A 
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4B.2. Data Collection, phasing, refinement and validation 
The dataset for NirE-SAH crystal was collected in house at a Rigaku MicroMax 007HF 
rotating anode X-ray generator, whereas the dataset for NirE-SAH-uro'gen III crystals 
was collected on beamline 14.2 of the Berliner Elektronenspeicherring-Gesellschaft für 
Synchrotronstrahlung. Both NirE-SAH and NirE-SAH-uro'gen III crystals belong to the 
space group C2221 and both diffracted up to 2.0 Å resolution. The dataset of NirE-SAH 
was processed with HKL 2000 (Minor et al., 2002) and scaled with SCALA (Evans, 
2006) of the CCP4 suite (CCP4, 1994). The dataset of NirE-SAH-uro'gen III, on the other 
hand, was processed and scaled with XDS and XSCALE (Kabsch, 2010). The Mathews 
coefficient (Mathews, 1968) for the two datasets were determined as VM = 2.29 Å3 Da-1 
and VM = 2.44 Å3 Da-1, which indicated the presence of only one NirE molecule in the 
asymmetric unit. MOLREP (Murshudov et al., 1997) was used to perform molecular 
replacement using the monomer of CobA (PDB ID - 1S4D) (Vevodova et al., 2004) as 
the search model. The solution obtained by MOLREP was manually corrected and 
rebuilt in COOT (Emsley et al., 2010). Following this, the model was refined using 
REFMAC through rigid body, restrained, and TLS refinement (Murshudov et al., 1997). 
At first, several rounds of rigid body and restrained refinement were performed and the 
final refinement was done by TLS refinement (Painter & Merritt, 2006) using 2 and 5 TLS 
groups as defined by the TLS Motion Determination Server (Painter & Merritt, 2006) for 
NirE-SAH and NirE-SAH-uro'gen III, respectively. In case of the NirE-SAH-uro'gen III 
crystals, unambiguous density for uro'gen III was found. Uro’gen III was modeled into the 
density by generating its PDB coordinates using PRODRUG (Schuttelkopf and Aalten, 
2004). After this, further refinement of the structure was performed. The Rwork and Rfree 
finally converged to 21.7% and 25.2%, respectively. The final Rwork and Rfree for the NirE-
SAH structure converged to 23.5% and 28.7%, respectively. Validation of the final 
models was done using MOLPROBITY (Davis et al., 2007). All the residues for every 
model fall into the allowed region of the Ramachandran plot (Ramachandran & 
Sasisekharan, 1968). 
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Table 2: Crystallographic data and refinement statistics 
 Dataset I 
NirE + SAH 
Dataset II 
NirE + SAH + Uro’gen III 
Data collection   
Beamline Rigaku MircoMax 007HF BESSY (BL14.2) 
Wavelength (Å) 1.541 0.91841 
Resolution (Å)a 46.3 - 2.0 (2.05 –2.00) 35.0 - 2.0 (2.05 –2.00) 
Space group C2221 C2221 
 
Unit cell parameters 
  
a,b,c (Å) 60.9, 115.1, 76.8 60.9, 116.2, 77.1 
α, β, γ (°) 90, 90, 90 90, 90, 90 
Unique reflectionsa 19,360 (1411) 18,362 (1418) 
Multiplicitya 4.4 (4.5) 3.9 (4.0) 
Completeness (%)a 98.82 (99.86) 92.6 (99.9) 
I/σIa 20.19 (2.58) 22.8 (4.0) 
Rmergea,b 0.043 (0.586) 0.083 (0.451) 
Wilson B (Å2) 35.1 34.4 
Solvent content (%) 46.4 49.7 
 
 
Refinement 
  
Rworkc 0.2349 0.2169 
Rfreed 0.2868 0.2526 
No. of atoms   
Protein 1,864 1,825 
Ligand 26 86 
Water 195 129 
Total 2,085 2,040 
   
Root mean square deviation from ideal 
Bond lengths (Å) 0.0239 0.0219 
Bond angle (°) 2.167 1.935 
 
Ramachandran plot 
  
Favored (%) 97.1 97.0 
Allowed (%) 2.9 3.0 
Disallowed (%) 0.0 0.0 
 
a Values in parentheses account for the highest resolution shell. 
b Rmerge= Rmerge = Σ|Io - 〈I〉| / ΣIo 
c Rwork= (Σ||Fo|-|Fc|| / Σ|Fo|); |Fo|: structure factors magnitudes observed; |Fc|: structure factors calculated. 
d Rfree is calculated as Rwork but from 5% randomly assigned reflections that are excluded from refinement. 
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The principal objective of this investigation was to obtain the enzyme-substrate complex 
structure of NirE with uro'gen III. To achieve this, NirE was incubated with 82-fold molar 
excess of uro’gen III that had been prepared by chemical reduction of uroporphyrin III 
with H2/palladium. In addition, the reaction by-product SAH was added to the NirE-
uro’gen III mixture, instead of SAM. The objective of this substitution was to prevent the 
catalytic conversion of uro'gen III and thereby trap the substrate in the active site of the 
enzyme. The resulting crystals of NirE from these crystallization set-ups had SAH and 
uro’gen III bound in its active site. In the refined NirE-uro’gen III complex structure, the 
localization, orientation, and conformation of the substrate was clearly defined by the 
additional electron density. The uro’gen III molecule binds above SAH and has partial 
contact with the solvent (Figure 29). In the omit map, initial electron density was clearly 
visible for the tetrapyrrole macrocycle, as well as for the acetate and propionate 
substituents of two opposite pyrrole rings (Figure 29). 
 
 
 
Figure 29: Substrate binding site of NirE. (A) Omit maps of SAH and uro’gen III calculated in the absence 
of the substrates from the final structure model. The 2Fo-Fc map is contoured to 1 σ and represented by a 
black mesh. The Fo-Fc map is contoured to 3 σ and represented by a green mesh. (B) 2Fo-Fc map of SAH 
and uro’gen III calculated in the presence of the substrates shown as black mesh contoured to 1 σ. 
B A 
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4B.3. Structure of NirE 
The NirE monomer is composed of two similarly sized domains (N-terminal domain, A 
and C-terminal domain, B) joined by a short linker (residues 130-133) (Figure 30A, B). 
Both domains are characterized by a central five-stranded β-sheet surrounded by five α-
helices. The β-strands of the N-terminal domain A (residues 1-129) are parallel and 
arranged in the order β-5 β-1 β-4 β-2 β-3 (the numbering represents the sequential 
appearance of β-strands in the NirE primary structure).The α-helices A, B, and C are 
located on the same side of the β-sheet, whereas D and E lie on the opposite side. 
Similar to the N-terminal domain A, the C-terminal domain B (residues 134-279) exhibits 
the same arrangement of secondary structure elements, with a central five-stranded β-
sheet core surrounded by five α-helices. However, the five β-strands of domain B are not 
arranged parallel to each other. In the mixed β-sheets of domain B, the strands are 
arranged in the order β-6 β-7 β-10 β-8 β-9. The α-helices F and J are located on one 
face of the mixed β-sheet, whereas α-helices G, H, and I occupy the opposite face. 
Although the two domains of the monomer exhibit the same arrangement of secondary 
structure elements, they differ in their topology (Figure 30A, B  
 
 
  
 
Figure 30: Structure of NirE. (A) Topology diagram of NirE. Helices are depicted as cylinders and β-
strands as arrows. The N-terminal and C-terminal domains are labeled as A and B, respectively. (B) 
Monomer of NirE (content of the asymmetric unit) in cartoon representation with SAH (light blue) and 
uro’gen III (light orange) shown as sticks.  
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The crystal structure revealed a homodimeric organization of NirE, which is in 
accordance with its dimeric state in solution. In the crystal structure, the homodimeric 
assembly of the protein molecule is created by a two-fold crystallographic symmetry axis 
(Figure 31A, B). In the NirE dimer, the five stranded β-sheets of both the C-terminal 
domains combine to form a single, slightly twisted ten-stranded β-sheet. The dimer has a 
total buried surface area of 5140 Å2. An interesting feature of this dimeric assembly is 
the long loop between α-helix F and β-strand, β-6 of domain B that extends into the 
active site pocket of the other monomer and participates in substrate binding and also 
plays a role in catalysis. In Figure 32A and B, this loop is highlighted in red. From the 
figure, an arginine residue is clearly seen to interact with uro’gen III at the active site of 
the other monomer. The dimeric arrangement and overall fold for NirE in the presence 
as well as in the absence of the bound substrate is highly similar. Apparently, there 
seem to be no marked conformational changes in the NirE backbone upon binding of 
uro’gen III. 
 
  
Figure 31: Dimeric organization of NirE. Cartoon representation of the physiological dimer of NirE created 
by a crystallographic symmetry operation (rotation axis is indicated by a dashed line). In the dimer, one of 
the two monomers is shown in a transparent shade of green. SAH and uro’gen III are represented as in 
Figure 29B. The two different views of dimeric NirE are related by a rotation about the two-fold symmetry 
axis of approximately 90°.  
A B 
90° 
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Figure 32: NirE dimer showing the flexible loop of domain B. (A) NirE dimer showing the presence of 
the flexible loop (highlighted in red) of one monomer extending into the active site pocket of the other 
monomer. (B) Magnified view of the NirE active site showing the arginine residue from the other monomer 
interacting with the substrate, uro’gen III. 
Uro’gen III 
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4B.4. Comparison of NirE with its homologues 
The highly conserved amino acid residues among SUMTs from different organisms were 
determined by an amino acid sequence alignment of more than 60 different SUMTs 
using CLUSTALW (Larkin et al., 2007). The residues which were identical in all SUMTs 
were identified as highly conserved. The amino acid sequence alignment of NirE with 
other SUMTs, whose structures have already been published namely, CysG (PDB ID - 
1PJQ) from Salmonella enterica, CobA (1S4D) from Pseudomonas denitrificans, and 
Thermus thermophilus ttSUMT (1V9A) revealed a sequence identity of 49%, 41% and 
40%, respectively. Thus, highest sequence identity was observed between NirE and 
CysG. A structure based sequence alignment of these four SUMTs was performed using 
ESPRIPT (Gouet et al., 1999) (Figure 33). The highly conserved amino acids could be 
mapped in the sequence alignment (indicated by a black star in Figure 33). The amino 
acids which were identical in all these four SUMTs are marked by a red box. The figure 
also highlights the helices and β-strands as found in the structure of NirE. Additionally, 
the amino acids, which formed the flexible regions that could not be included in the final 
structure, have been indicated by dashed green lines. Based on this sequence 
alignment and structural analysis of SAH and uro’gen III in the active site of NirE, several 
residues were identified for site directed mutagenesis (indicated by a blue triangle in 
Figure 33).  
The structure of NirE was found to be highly similar to the above mentioned SUMTs. The 
root mean square deviations between common Cα positions are 0.603 Å for NirE and 
CobA, 0.776 Å for NirE and CysG and 0.836 Å for NirE and ttSUMT. Hence, NirE and 
Cob A demonstrate the highest degree of structural similarity. Structural comparison of 
the four SUMTs further revealed the existence of two flexible loops in all the four 
structures. Figure 34 shows the superposition of NirE with the structures of the three 
SUMTs in ribbon representation. In the NirE structure, these loops are located between 
β-3 and α-helix D of domain A and between the β-6 and α-helix G of domain B. In Figure 
34, the beginnings and ends of flexible loops are indicated by a star and an arrow head. 
These two loops have been found to be predominantly constituted of disordered amino 
acids in all SUMTs. Although the flexible loop of domain B does not exhibit the presence 
of any highly conserved amino acid residue, the domain A loop harbors a highly 
conserved lysine (Lys-72 in NirE). The corresponding lysine in CysG (Lys-270) was 
found to be a functionally essential residue (Stroupe et al., 2003). Similar to other 
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SUMTs, in the structure of NirE-uro’gen III complex, the two flexible loops were still 
found to be disordered and Lys-72 was not included in the final model. Hence, the exact 
function of this lysine residue is yet to be ascertained. 
 
 
Figure 33. Comparison of NirE with its homologues. Structure based amino acid sequence alignment of 
NirE from Pseudomonas aeruginosa (NirE_PA) with the SUMT domain of CysG from Salmonella enterica 
(CysGA_SE) (Stroupe et al., 2003), a SUMT from Thermus thermophilus (SUMT_TT) (Rehse et al., 2005) 
and CobA from Pseudomonas denitrificans (CobA_PD) (Vevodova et al., 2004). Helices and β-strands as 
found in NirE are indicated. The amino acids that formed the flexible regions and could not be included in 
the final structure have been indicated by dashed green lines. The identical amino acids among these four 
SUMTs are highlighted by red boxes, whereas the highly conserved amino acids as identified by an amino 
acid sequence alignment of 60 SUMTs from different organisms are marked by a black star. The amino acid 
residues which were subjected to mutational analysis in this study are highlighted by blue triangles. (Figure 
adopted from Storbeck et al., 2011) 
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Figure 34: Structural comparison of NirE with its homologues. Superposition of NirE (green) with the structures of CobA (salmon), the SUMT domain of CysG 
(blue) and ttSUMT (yellow). The structural models are shown in ribbon representation. The beginnings and ends of flexible loops are indicated by a star and a 
triangle, respectively.  
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4B.5. Binding of SAH and Uro'gen III at the active site of NirE 
SAH was found to bind in a pocket between the two domains of the NirE monomer. 
In both the structures of NirE, i.e. with and without bound uro’gen III, SAH was buried 
deep inside this pocket (Figure 35). Consistent with the previously published SUMT 
structures, the SAH molecule adopts the same bent conformation in both the NirE 
monomers. The localization and coordination of SAH in both the structures are 
identical irrespective of the presence or absence of uro'gen III. Figure 35 shows a 
stereo view of the amino acids involved in the coordination of SAH in the NirE active 
site. Polar contacts between SAH and the protein mainly involve hydrogen bonds 
and salt bridges. The amino acids involved in such interactions are Pro-27, Gln-217, 
Gly-215, Thr-243, Thr-133, Asp-105, Ile-108 and Met-186. The amino acids 
contributing to the hydrophobic interactions are Leu-52, Tyr-185 and Pro-242. Pro-
242 contributes to the hydrophobic environment of the adenine ring of SAH, whereas 
Tyr-185 stacks along the aliphatic part of the homocysteine moiety. A schematic two-
dimensional representation of the interactions between SAH and the active site 
residues of NirE has been shown in figure 36. 
 
 
Figure 35: Stereo view of the orientation of SAH in the NirE active site. SAH (blue) along with the 
amino acids (green) involved in its coordination at the enzyme active site are shown as sticks. The 
dotted lines represent salt bridges or hydrogen bonds. 
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Figure 36: Interaction of SAH with the amino acids in the active site of the enzyme. Schematic 
two-dimensional representation of the amino acids involved in the coordination of SAH in the enzyme’s 
active site. The dotted line represents a salt bridge or a hydrogen bond with their lengths given in 
Angstroms. The amino acids involved in hydrophobic interactions are surrounded by a red corona. This 
figure was created with the program LIGPLOT. 
SAH 
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While binding to NirE, uro'gen III adopts a twisted “two-up, two-down” conformation, 
i.e. the two pyrrole rings facing each other point in the same direction, either upward 
or downward, out of the tetrapyrrole plane (Figure 36 and 37). Pyrrole rings B and D 
point upward whereas the rings A and C point down towards the interior of the active 
site pocket and the bound SAH. Rings B and D are both inclined by about 45°, 
whereas rings A and C are inclined at an angle of about 70° and 60° out of the 
tetrapyrrole plane, respectively. The enzyme-product complex structure of uro’gen III 
synthase also exhibited such a “puckered” conformation (Schubert et al., 2008). 
Interestingly, Met-186 is located directly below the tetrapyrrole and stacks against 
pyrrole rings B and D with its sulfur atom being placed beneath the exact centre of 
the macrocycle (Figure 37A, B). Apart from the interaction between Met-186 and 
uro’gen III, another hydrophobic contact between the substrate and the protein is 
provided by the residue His-161. The imidazole ring of His-161 stacks against pyrrole 
ring C of uro’gen III (Figure 37A).  
Polar contacts (hydrogen bonds or salt bridges) between the enzyme and the 
substrate mainly involve the eight carboxylate groups of the acetate and propionate 
substituents of uro’gen III with three conserved arginine residues Arg-51, Arg-111 
and Arg-149, the NirE protein backbone and several water molecules (Figure 37, 38; 
water molecules omitted for clarity). The guanidinium group of Arg-111 participates in 
a polar contact with the acetate carboxylate of ring A. The acetate carboxylate also 
forms hydrogen bonds with three water molecules, while the propionate carboxylate 
of this same ring forms a polar contact to the guanidinium group of Arg-51. 
Additionally, this arginine residue also participates in a polar interaction with the 
carboxylate group of the acetate substituent of ring B. The ring B propionate side 
chain is held in its position by hydrogen bonds to the backbone N-H group of Gly-189 
and two water molecules. The acetate carboxylate group of ring C forms hydrogen 
bonds with three water molecules. The propionate carboxylate of the same ring also 
makes a hydrogen bond with a water molecule. The highly conserved amino acid 
Arg*-149, which belongs to the polypeptide chain of the second monomer of dimeric 
NirE (indicated by an asterisk,*) and is located in the flexible loop between α-helix F 
and β-6 of the C-terminal domain B, also makes an indirect contribution to the 
coordination of uro’gen III in the active site. A two dimensional representation of 
these interactions is shown in Figure 38.  
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Figure 37: Active site of NirE. (A) Stereo top view and (B) stereo side view of the NirE active site. 
Important amino acids are shown as sticks. The chain of monomer A is dark green and that of monomer 
B is purple. The hydrogen bonds and salt bridges are drawn as black broken lines.  
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Figure 38: Substrate binding site of NirE. Schematic representation of the interactions between NirE 
and uro’gen III. Dotted line represents a salt bridge or a hydrogen bond with their lengths given in 
Angstroms. The Arg*-149 of the other monomer is shown in purple. The red corona around His-161 
represents hydrophobic interactions with uro’gen III. This figure was created with the program LIGPLOT. 
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Of the three highly conserved arginine residues which have been implicated in the 
coordination of the substrate’s carboxylate groups, two residues, Arg-51 and Arg*-
149, clearly change their orientation upon substrate binding (Figure 39). In the 
absence of uro'gen III, the NirE structure shows the guanidinium group of Arg-51 
pointing upwards. However, upon substrate binding, it moves down.  A significant 
change in the orientation of the side chain of Arg*-149 is also observed depending on 
the absence or presence of the substrate. In the absence of bound uro’gen III, this 
arginine residue makes a salt bridge with the adjacent Asp*-150 in the same 
monomer. Upon substrate binding, the guanidinium group is flipped to point to the 
opposite direction towards the active site of the other monomer in dimeric NirE, 
where it participates in the coordination of the ring C and D carboxylate groups 
(Figure 39). Another change in the position of amino acids is observed for His-161. 
This histidine residue is part of the flexible loop of the C-terminal domain of NirE and 
moves slightly backwards upon substrate binding, in order to accommodate the 
tetrapyrrole (Figure 39). 
 
Figure 39: Active site of NirE. Superposition of the NirE active site in the presence (green) and 
absence (gray) of uro’gen III. Amino acid residues Arg-51, Arg*-149 and His-161 clearly change their 
orientation upon substrate binding. 
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4B.6. Generation of NirE variants carrying amino acid exchanges of 
residues potentially involved in catalysis 
 
The structure of NirE-uro’gen III complex provided an insight into the direct amino 
acid environment of the substrate uro’gen III in the active site of a SUMT for the first 
time. This structure revealed the amino acids surrounding uro’gen III that could be 
involved in substrate binding and/or play a role in catalysis. Based on this structure, 
amino acid residues, which could have a possible role in catalysis, were identified for 
site directed mutagenesis. Sonja Storbeck, as a part of her PhD thesis, performed 
the site-directed mutagenesis. Previously, it has been suggested that a basic amino 
acid residue is possibly involved in proton abstraction from uro’gen III, that initiates 
the SAM-dependent methyl transfer reaction (Guillen Schlippe et al., 2005). The 
possible site of this H+ abstraction could either be a methylene bridge between the 
pyrrole rings (most likely the C-20 position for the first methylation), or a pyrrole N-H 
group. Following the transfer of methyl group from SAM onto uro’gen III, there occurs 
a rearrangement of bonds within the tetrapyrrole macrocycle (Stroupe et al., 2003, 
Warren et al., 1994). It is possible that the NirE active site’s amino acid residues 
promote this prototropic rearrangement through acid/base catalysis.  
After a detailed structural analysis of the active site of NirE, the following conserved 
basic residues were selected for site-directed mutagenesis: Arg-51, Lys-102, Arg-
111, Arg*-149, and His161. Arg-51 is located near the methylene bridge C-5 between 
rings A and B, the residues Arg-111 and Arg*-149 are close to the C-20 position 
between rings A and D, and finally His-161 is located in the direct neighborhood of 
methylene bridge positions C-10 and C-15 as well as the N-H group of ring C. His-
161 was replaced by a phenylalanine. This exchange was done with the aim to knock 
out the putative function of His-161 as a catalytically active base, while retaining its 
hydrophobic stacking interaction with pyrrole ring C.  
Although arginine is considered to be a weak base, several examples in the literature 
have previously been reported, demonstrating the involvement of arginine residues in 
proton abstractions (Guillen Schlippe et al., 2005). In these cases, the location of the 
arginine residues is characterized by their accessibility to solvent molecules and 
close proximity to the carboxylate groups of the aspartate or glutamate side chains. 
In the active site pocket of NirE, an acidic environment is created by the highly 
conserved residues Glu-114 as well as the substrate’s own carboxylate groups, 
which are close to the conserved arginine residues Arg-51, Arg-111, and Arg*-149. 
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Hence, all three arginines along with Glu-114, were subjected to site-directed 
mutagenesis. Arginines were exchanged against lysines and the glutamate was 
exchanged against glutamine. 
Further to the above mutations, Met-186 was also selected for mutational analysis 
based on its strategic location at the center of the active site and its contribution in 
binding to both SAH and uro'gen III. In order to investigate the role of this highly 
conserved methionine, it was replaced by a leucine. This substitution is more 
conservative than the previously reported methionine to alanine exchange in CobA 
from Pseudomonas denitrificans, which resulted in a complete loss of enzyme 
activity (Vevodova et al., 2004).  
Finally, Gly-189 was selected for replacement by an asparagine or a lysine based on 
the superposition of NirE with the structures of CysG and CobA, in which it 
corresponds to Asp-385 and Lys-187, respectively. The superposition revealed the 
potential of Asp-385 and Lys-187 to make polar contacts with the propionate 
carboxylate of the substrate’s ring B. Hence, the mutagenesis of Gly-189 was 
designed with the aim to study the positional importance of an asparagine or a lysine 
in NirE.  
All NirE variants were expressed in E. coli, purified, and analyzed for their ability to 
bind SAM and for catalytic SUMT activity by Sonja Storbeck as a part of her Ph.D. 
thesis. A summary of the results obtained by her is shown in Figure 40A and B. 
4B.6.1. Exchange of amino acid residues Arg-51, Arg-111, Glu-114, Arg*-
149, His-161 and Gly-189 does not disturb SAM binding 
The binding affinity of SAM to NirE variants G114Q, R149K, and H161F remained 
unchanged compared to the wildtype protein. A slightly reduced (about 75 % of wt) 
SAM binding was observed in the case of the NirE variants R51K, R111K, G189N, 
and G189K.  The protein variant M186L exhibited a significant decrease in SAM 
binding (about 40 % of wt) and the K102A variant demonstrated a highly reduced 
ability to bind the cofactor (about 20 % of wt). However, the binding of SAM to the 
M186L variant was strong enough for performing SUMT activity assays and 
investigating the role of Met-186 in uro’gen III binding and NirE catalysis. The 
reduced affinity for SAM of K102A was unsuspected as it is not present in the 
immediate neighborhood of the cofactor. Figure 40 B shows the SAM binding ability 
of wildtype NirE and the NirE variants. 
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4B.6.2. SUMT activity assay 
Two slightly different assay systems were employed to measure the SUMT activity of 
NirE wildtype and variants. One of them involved the determination of overnight 
production of sirohydrochlorin (Figure 40A) whereas the latter measured the specific 
activity (i.e. the initial reaction rates) (Figure 40B). These assays were done by Sonja 
Storbeck as a part of her Ph.D. thesis. 
 
 
Figure 40: NirE enzymatic activity. (A) UV-Vis absorption spectra of sirohydrochlorin formed in NirE 
activity assay mixtures containing either wildtype NirE or variants thereof. (B) The specific activity of 
wildtype NirE and NirE variants was determined as described in Materials and Methods using 
chemically produced uro’gen III as the substrate at a final concentration of 17 µM. In contrast to the 
overnight activity assay (panel B) the values for the specific activity represent the initial reaction rates. 
The given values represent the average of three independent measurements. The SAM binding ability 
of wildtype NirE and NirE variants was determined as described in Materials and Methods. The strength 
of SAM binding is represented as identical to wildtype NirE (+ + + +), slightly reduced (+ + +), reduced 
(+ +) and strongly reduced (+) 
 
Except for G189N and G189K, all analyzed NirE variants exhibited a reduced SUMT 
activity compared to the wildtype. In the case of the G189K variant, two-fold increase 
in specific activity was observed. The most pronounced reduction in SAM binding 
ability was observed for the variants K102A and M186L. Additionally, a complete loss 
of SUMT activity was seen in the case of Lys-102 when exchanged against an 
alanine residue. The M186L variant which showed a relatively low affinity of cofactor 
binding (of about 40% compared to wildtype) retained only a residual amount of 
catalytic activity. NirE variants R51K and H161F retained their SAM binding ability 
but demonstrated reduced specific SUMT activities. However, both variants were still 
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clearly able to catalyze the methyl transfer reaction. The overnight incubation assay 
revealed that the amount of precorrin-2 produced by them almost equaled that of 
wildtype NirE.  
Similar to R51K and H161F, the NirE mutants R111K and R149K are also 
characterized by an ability to bind SAM, but have reduced enzymatic function. 
However, the NirE mutants R111K and R149K still had the ability to form precorrin-2, 
but both of them demonstrated drastically reduced SUMT activity. Interestingly, both 
arginines, Arg-111 and Arg*-149, are strategically located in close proximity to the 
uro’gen III C-20 position, which is a possible site of the proton abstraction. 
Additionally, both arginines are in close contact to several carboxylate groups which 
are originating either from the substrate or from the protein. This creates an 
environment conducive for them to act as base for proton abstraction (Guillen 
Schlippe et al., 2005). The strictly conserved Glu-114 is also in close contact to Arg-
111, which facilitates in positioning it near the substrate. To investigate this 
hypothesis, the conserved Glu-114 was exchanged with a glutamine. This resulted in 
a NirE E114Q variant with a SAM binding ability similar to the wildtype NirE, but with 
significantly reduced SUMT activity. 
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5. Discussion 
5B. Role of Cnx1E in the synthesis of the molybdenum 
cofactor 
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5A.1. Active site of Cnx1E 
Structural comparison of Cnx1E sub-domain 3 with Cnx1G revealed a high degree of 
similarity. Apart from minor structural variations, the overall architecture of the two 
structures is largely the same. This strongly indicates that that sub-domain 3 harbors 
the active site of Cnx1E catalyzing the deadenylation of MPT-AMP. Previous 
structural analysis of the Cnx1G-MPT complex provided a detailed insight into its 
active site pocket. MPT was found to bind in a large predominantly negatively 
charged cavity within the compact globular protein (Figure 41A). The amino acid 
residues involved in MPT binding are located on one side of this cavity whereas the 
residues involved in catalysis are on the other side (Figure 41A). Three residues Thr-
542, Ser-573 and Ser-583 were found to be involved in binding and coordination of 
MPT whereas the residues essential for catalysis are Ser-476, Asp- 486, Asp-515, 
Asp-548 (Kuper et al., 2003, Kuper et al., 2004).  
Similar to Cnx1G, the sub-domain 3 of Cnx1E was also found to possess a 
negatively charged cavity on one side of the molecule (Figure 41B). The cavity is 
however much larger in the case of Cnx1E. Three out of four catalytically important 
aspartate residues (Asp-486, Asp-515 and Asp-548) of Cnx1G are conserved in sub-
domain 3 of Cnx1E. The corresponding residues in Cnx1E are Asp-217, Asp-200 
and Asp-274 (Figure 41B), of which Asp-274 has already been established as a 
functionally relevant residue (Corinna Probst, Master’s Thesis, 2012). Previous 
studies have shown that molybdate and MPT-AMP bind cooperatively to Cnx1E. 
Hence, the high positive charge of the surface immediately next to the negatively 
charged cavity must be the reason to facilitate the binding of the negatively charged 
molybdate. It is already known that the binding of molybdate at the sub-domain 3 of 
Cnx1E is essential for the insertion of molybdenum into MPT. The hydrolysis of MPT-
AMP and insertion of molybdate into MPT take place subsequently. Hence, on the 
basis of this comparative analysis of the structure of the active site pocket of Cnx1G 
to the cavity observed on the surface of domain 3 of Cnx1E, it can be concluded that 
MPT upon being adenylated by Cnx1G is received by the sub-domain 3 where it gets 
further processed to yield mature Moco.   
 
  89 
   
 
 
 
 
 
 
Figure 41: Surface representation of the active site of Cnx1G and Cnx1E putative active site. (A) Negatively charged active site pocket of Cnx1G. Amino acids involved in 
substrate coordination were mapped on one side of this cavity (yellow) whereas the residues involved in catalysis were mapped on the other side (blue). (B) Negatively charged 
putative active site pocket observed on the surface of the domain 3 of Cnx1E with the conserved corresponding amino acids of Cnx1G that are implicated in catalysis. 
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5A.2. Cnx1E: A nudix hydrolase 
Cnx1E can be classified as a ‘nudix hydrolase’, based on its functional role in 
catalyzing the hydrolysis of MPT-AMP to yield Moco. Nudix hydrolases is a subfamily 
within the enzyme superfamily of pyrophosphate hydrolases. The name of this 
superfamily is derived from their substrates as they catalyze the hydrolysis of 
pyrophosphate bond of nucleoside diphosphate linked to another moiety (X), hence 
the name nudix. Hydrolysis reaction of these enzymes is dependent on divalent 
cations that in most of the cases are Mg2+. A prominent example of a nudix hydrolase 
is MutT from E. coli. that catalyzes the hydrolysis of the base analogue 8-oxo-dGTP. 
MPT-AMP represents a nudix substrate with the adenosine linked to the MPT moiety 
by two phosphate bonds and thus, closely resembles the substrate of MutT, which is 
8-oxo-dGTP (Figure 42A, B). Additionally, the catalytic function, Mg2+ dependent 
MPT-AMP hydrolysis of Cnx1E is also similar to MutT.  
 
 
  
Figure 42: Chemical structures of the substrates of nudix hydrolase. (A) 8-oxo-dGTP, a substrate 
of MutT from E.coli, (B) MPT-AMP 
 
Comparative structural analysis of nudix hydrolases with Cnx1E further asserted its 
classification in this enzyme family. Nudix hydrolases are characterized by a 
conserved amino acid sequence known as the nudix motif or the nudix box, 
GX5EX7REUEXEEXGU, where X is any amino acid and U is a bulky aliphatic 
hydrophobic residue. The nudix box folds into a loop helix loop motif, the core of 
which is mainly formed of glutamic acid residues. These glutamic acid residues play 
an important role in binding to divalent cations, which in most of the cases are Mg2+ 
ions. Although this loop helix loop motif is not involved in substrate binding, it forms 
the catalytic site of the enzyme.  
A B 
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The structure of MutT solved in 2010 (PDB ID - 3A6U)(Nakamura et al., 2010), 
revealed the presence of a loop helix loop motif composed of the nudix box amino 
acid sequence in the active site. A similar nudix box motif could be mapped to the 
domain 3 of Cnx1E (Figure 43A, B), which formed the familiar loop helix loop motif 
(Figure 43D). It contains the α-helix G and the two loops joining this helix to the β-
strands β-12 and β-13. This helix is slightly shorter than the helix of the MutT nudix 
motif (Figure 43C). Although the amino acid residues exhibit less significant 
sequence identity to nudix box consensus sequence, they show a significant identity 
amongst each other. In addition to this, the functionally relevant amino acid Asp-274 
is part of this motif. This further reinforces the hypothesis of sub-domain 3 harboring 
the active site of the enzyme. 
 
 
 
 
  
Figure 43: Structure of the putative Nudix box motif of Cnx1E and its location in the tertiary 
structure. (A) The Cnx1E monomer with the nudix motif colored in blue. The individual sub-domains are 
denoted by roman numbers alongside. (B) Detailed view of domain3 of Cnx1E showing the location of 
the nudix motif, (C) the loop-helix-loop motif of the nudix hydrolase which contains the nudix box, (D) 
Putative nudix motif of Cnx1E. 
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5A.3. Functional characterization of residues implicated in catalysis and 
substrate binding 
The presence of bound MPT-AMP in all the four cases confirmed that the mutants 
were not completely active. On comparing the MPT-AMP content of the four mutants 
with each other, it is seen that the introduction of an additional G108D mutation 
results in a partially active enzyme as indicated by the reduced MPT-AMP content. 
This is contradictory to previous studies where G108D mutation was seen to 
increase the MPT-AMP content of the enzyme. Additional experiments based on the 
analysis of molybdate saturation in Cnx1E further confirmed the above results. On 
comparing the molybdate saturation with determined amounts of MPT-AMP bound to 
the same variants, it is seen that the molybdate or MPT-AMP matches saturation 
ratios of the four variants. Hence, the direct relation of cooperative binding of 
molybdate and MPT-AMP to Cnx1E was clearly established. On this basis, we can 
determine MPT-AMP saturation in Cnx1E variants by the colorimetric determination 
of molybdate saturation. 
In addition to the above experiments, the MPT-AMP hydrolysis proved that the four 
Cnx1E variants were indeed MPT-AMP hydrolysis mutants. Hence, based on the 
results of biochemical characterization and functional assays, it is concluded that 
Asp-274 which is located in the sub-domain 3 of Cnx1E is crucial for biocatalytic 
property of the enzyme. 
 
5A.4. Implication of Asp-274 on the enzymatic mechanism 
the structural analysis and biochemical results, the potential mechanism MPT-AMP 
hydrolysis involving the role of the amino acid Asp-274 in Cnx1E can be proposed. E. 
coli Nudix hydrolase MutT was used as a model for the functional assignment of the 
amino acid to the reaction mechanism of the Asp-274 in Cnx1E. MutT catalyzes a 
nucleophilic substitution (SN). The mechanism is shown in Figure 4.2 A. 
 
As seen in all Nudix hydrolases, the catalytic activity of MutT is also based on a 
Nudix box. In MutT, the amino acids of the nudix box have been entrusted with two 
functions. Firstly, they are responsible for the coordination of the Mg 2+, which is 
involved in the catalysis of the hydrolysis reaction. The second task of the Nudix box 
amino acids is the formation of the actual nucleophile. The amino acid Glu-53 acts as 
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a general base and abstracts a proton from a  water molecule. This results in the 
weakening of the OH bond of the water, thereby increasing the negative charge of 
the water molecule which favors the nucleophilic attack by this water molecule on the 
phosphate (Mildvan et al., 2004).  
 
 
 
 
Figure 44: Reaction mechanism of MutT. Reaction mechanism of MutT showing the hydrolysis of 
phosphate bond catalyzed by Glu-53. 
 
Based on the functional characterization and the location of the amino acid Asp-274 
in the putative catalytic site, a speculation could be made. It is possible that Cnx1E 
Asp-274 is the corresponding residue to Glu-53 of MutT. Hence, Cnx1E Asp-274 
might be involved in a nucleophilic attack on a water molecule which would then be 
available for attacking the phosphate bond between MPT-AMP.  However, in the 
absence of the structure of an enzyme-substrate complex it is impossible to arrive at 
a definite conclusion. Hence, this needs further investigation. 
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5B. Role of NirE in the synthesis of the tetrapyrrole Heme d1 
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5B.1. Active site of NirE 
The high degree of structural similarity of NirE to the previously published SUMTs, 
suggested that NirE shares similar active site architecture with other members of this 
enzyme family. This belief was further supported by the location of the catalytic 
pocket between the two domains of each monomer, a characteristic structural feature 
of SUMTs (Stroupe et al., 2003, Vevodova et al., 2004, Rehse et al., 2005). A 
remarkable similarity is observed in the coordination of the SAH molecule in the 
active site of NirE and CysG, which apparently also exhibits the highest degree of 
amino acid sequence identity to NirE compared to the two other crystallized SUMTs. 
The acetate and propionate groups were unambiguously distinguishable from the 
size and shape of the electron density for these substituents and hence it was 
possible to assign the respective pyrrole rings as rings B or D. This presented two 
possible orientation of the uro’gen III molecule which could be inter-converted by a 
180° over-head flipping action of the molecule while keeping the positions of rings A 
and D unchanged. However, on the basis of the known stereochemistry of the 
methylation reaction and the location of the SAH molecule beneath one face of 
uro’gen III, only one of the two orientations was possible. In the structure of NirE in 
complex with uro’gen III, the orientation of the substrate shows rings A-D arranged in 
a clockwise manner when viewed from top. The central part of the substrate is 
stabilized by the residue Met-186 that provides a hydrophobic environment and 
forms hydrogen bonds (~3.5 Å each) with the N-H groups of pyrrole rings A and C 
(Figure 38). The angles and distances between the Met-186 sulfur and the A and C 
rings’ N-H groups are in accordance with the presence of these unusual sulfur-
containing H-bonds (Zhou et al., 2009). Therefore, it could be rightly said that Met-
186 is important for the binding of both SAM and uro’gen III. The role of this 
methionine in substrate binding has also been experimentally observed in a 
Pseudomonas denitrificans CobA variant in which the corresponding methionine 
residue (Met-184) on being replaced by an alanine was unable to bind SAM and 
showed almost no SUMT activity (Vevodova et al., 2004). 
Overall, the coordination between the acetate and propionate substituents of uro’gen 
III and the surrounding amino acid residues is quite loose and the substrate is not 
very tightly fixed. A positively charged environment is provided by the arginine 
residues Arg-111, Arg-51, and Arg*-149 and possibly also by the highly conserved 
Lys-72 lying on the disordered loop of domain A. This environment accommodates 
the carboxylate groups of the substrate. This loose coordination of the substrate’s 
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carboxylate groups is reflected in a relatively high temperature factor (58.8 Å2 
compared to the average temperature factor of 34.4 Å2) and a weaker electron 
density for the substrate compared to that of SAH (Figure 20A).  
The fact that the enzyme has to bind the mono-methylated precorrin-1 in the same 
active site pocket as that of uro’gen III in order to perform the second methylation at 
C-7 justifies this relatively loose enzyme-substrate coordination. It further explains 
the ability of SUMTs to accept uroporphyrinogen isomers other than uro’gen III, such 
as uro’gens I, II, or IV, as substrates (Warren et al., 1990, Scott et al., 1989). 
 
5B.1.1 Lys-102 and Met-186 are the two key residues that are primarily 
involved in SAM binding  
As expected from structural analysis, the results of the SAM binding assay, showed 
that the residues Arg-51, Arg-111, Glu-114, Arg*-149, His-161, and Gly-189 do not 
play a crucial role in binding SAM. Hence, any decrease in SUMT activity as a result 
of their substitution should be implicated to their involvement in the coordination of 
uro’gen III or NirE catalysis. The M186L variant was expected to demonstrate a 
reduced SAM binding ability as the structure of NirE as well as CobA and CysG 
structures had revealed the hydrophobic interaction between the SAH and this 
methionine residue. One surprising finding from this assay was the highly reduced 
SAM binding ability of K102A as it is not present in the immediate neighborhood of 
SAM. However, this lysine residue participates in an extended network of hydrogen 
bonds involving the residues Glu-115, Gly-110, Arg-100, Gln-81, and Asp-50.  
Except Arg-100, all these amino acid residues are highly conserved in SUMTs from 
different organisms. Hence, it could be concluded that Lys-102 along with the amino 
acid residues mentioned above contribute to the overall structural integrity of the 
active site. 
5B.1.2. Amino acids Arg-51, His-161, and Met-186 are involved in uro’gen 
III coordination. 
The primary amino acids involved in uro’gen III coordination are Arg-51, His-161, and 
Met-186. This is clearly seen in the structure of NirE-uro’gen III complex and was 
experimentally proved by the enzyme assay. It was expected that the NirE variants in 
which amino acids had been replaced that play a role in substrate binding but have 
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no direct contribution in catalysis, would demonstrate a decrease in specific activity 
but an equal overnight activity compared to the wildtype NirE. Both R51K and H161F 
mutants were observed to retain their ability to methylate uro'gen III and form 
precorrin-2. Hence, the reason for their reduced specific activity was attributed to 
their reduced substrate affinity that resulted in impaired substrate coordination at the 
active site. Initially, these two amino acids were also considered suitable to act as 
base for proton abstraction from uro'gen III. However, the retention of the catalytic 
activity in these two mutants ruled out that hypothesis.  
Met-186 and Lys-102 are the two residues that are involved in both SAM and uro'gen 
III binding. The significant decrease in SAM binding ability coupled with reduced 
SUMT activity reinforced their role in substrate coordination. K102A variant was 
marked by a complete loss of catalytic activity which could possibly be attributed to a 
disruption in the active site architecture resulted by the replacement of lysine by 
alanine. However, in the case of M186L, the reduced SAM affinity of 40% compared 
to wildtype NirE and retention of residual SUMT activity proved its critical role in SAM 
and uro'gen III coordination, which is also indicated by its strategic location in the 
active site. This suggests that the sulfur atom of the methionine is possibly involved 
in correctly positioning the substrate through hydrogen bonds with the N-H groups of 
pyrrole rings A and C. 
The sharp increase in the activity of the NirE variants G189N and G189K could be 
attributed to a more precise and specific binding of uro’gen III and precorrin-1 
through polar contacts between the asparagine or lysine side chains with the 
carboxylate groups of the substrates. There is a marked similarity in the active sites 
of the NirE variants G189N and G189K and those of CysG and CobA, respectively. 
Interestingly, these two enzymes also exhibited a higher specific activity than NirE in 
previous studies (Stroupe et al., 2003, Vevodova et al., 2004).  
 
5B.1.3. Amino acids Arg-111, Glu-114 and Arg*-149 are involved in NirE 
catalysis. 
Mutational analysis clearly established the direct involvement of Arg-111, Arg*-149 
and Glu-114 in NirE catalysis. The biochemical results strongly suggest that both the 
arginines are suitable to act as a base in order to abstract a proton from Uro'gen III. 
The positive charge of the Arg-111 is further enhanced by Glu-114 by forming a polar 
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contact with it. Hence, it can be rightly concluded that Arg-111, Arg*-149 and Glu-
114, in addition to the coordination of the substrate’s carboxylate side chains, they 
have a direct part in catalysis. However, it is difficult to state which of the two 
arginines, Arg-111 or Arg*-149 act as the base to initiate proton abstraction  
Both the arginines are equally suited for the role of the base owing to their polar 
contacts with carboxylate groups. The substrate’s ring A acetate side chain and the 
carboxylates of Glu-114 form polar contacts with Arg-111 whereas in the case of 
Arg*-149, such polar contacts are furnished by the substrate’s ring D acetate side 
chain and ring C propionate substituent. It has been previously proposed that such a 
carboxylate-rich environment is a common motif for some proteins that use arginine 
residues as the catalytically essential base (Guillen Schlippe et al., 2005). The role of 
carboxylate in such reactions has been stated to facilitate the rapid exchange of 
protons with the solvent. Additionally, solvent accessibility of their active sites is 
another requirement of this group of enzymes. This feature is clearly seen in the 
case of NirE from the structure of NirE-uro’gen III complex.  
On considering the distances of the two arginine residues from the C-20 position, 
there seems a slight advantage of Arg*-149 over Arg-111. In the case of Arg*-149, 
the closest guanidinium NH2 group to C-20 is at a distance of 4.66 Å whereas for 
Arg-111 this distance is 4.75 Å. The terminal amide group of this residue is located at 
a distance of 6.15 Å to C-20. Since SAH is bound to the NirE-substrate structure, 
which is devoid of the methyl group, it allowed for a deeper positioning of the uro’gen 
III than would have SAM. Hence, in the presence of the true co-substrate, SAM in the 
active site, the substrate’s C-20 position would move even closer to the both arginine 
residues. Such competing facts could also mean that both Arg-111 and Arg*-149 are 
required for catalysis. Another striking observation that might explain this hypothesis 
is their direct neighborhood to each other. In fact, the two guanidinium groups are 
arranged almost parallel to each other with a distance of about 3.5 Å. This close 
proximity creates the opportunity for the positive charge of one of the guanidinium 
groups to favor the deprotonated state of the other which would then be available for 
proton abstraction from C-20. In the absence of the substrate, Arg*-149 forms a salt 
bridge with Asp*-150 in the same monomer. Upon substrate binding, the side chain 
of Arg*-149 moves away from Asp*-150 towards the active site of the other monomer 
of the NirE dimer where it participates in polar contacts with two carboxylate side 
chains of the substrate. This new position of Arg*-149 brings it closer to the Arg-111 
residue that favors the deprotonation of the former.  Subsequently, uncharged Arg*-
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149 can then act as the base and abstract a proton from C-20. However, the reverse 
of this theory is also possible. 
 
5B.2. Implications for the catalytic mechanism of NirE and other SUMTs.  
The crystal structure of NirE in complex with its substrate uro’gen III presented an 
opportunity to identify a set of amino acid residues that possibly bring about the 
catalytic transformation of uro’gen III to precorrin-2. Further investigation based on 
biochemical analysis of the functional role of these residues on NirE enzyme activity 
narrowed down this list to three amino acids: the two arginines, Arg-111 and Arg*-
149 and the Glu-114, all of which have a direct involvement in catalysis. All these 
three residues are highly conserved among different SUMTs from various organisms. 
On the basis of localization of Arg-111, Arg*-149 and Glu-114 with respect to the 
substrate uro’gen III observed in the crystal structure, a potential mechanism for NirE 
could be postulated, which can very rightly be applied to all members of the SUMT 
family (Figure 45). Previously, it has already been proposed that the methyl transfer 
reaction in SUMTs is initiated by a proton abstraction from the substrate uro'gen III 
(Guillen Schlippe et al., 2005). On the basis of structural information obtained from 
the enzyme- substrate complex of NirE-uro’gen III and functional characterization of 
NirE variants, it is concluded that either Arg-111 or Arg*-149 acts as the catalytically 
active base and is responsible for proton abstraction from C-20 of uro’gen III thereby 
facilitating the nucleophilic attack of C-2 at the methyl group of SAM. 
Structural analysis of the active site of the enzyme-substrate complex revealed that 
that puckered conformation of uro’gen III in the enzyme active site, results in closer 
positioning of the N-H group of ring A to the sulfur atom of SAH while leaving the C-2 
atom at a relatively large distance to the SAH sulfur (6.15 Å). To investigate the 
compatibility of this puckered conformation of uro'gen III in the presence of SAM in 
the active site, SAH was replaced with SAM by in silico modeling under the 
assumption that it would adopt an identical conformation. The basis of this 
assumption was the crystal structures of SAM complexes (e.g. PDB ID 3GX3 and 
3GX6, (Montange et al., 2010)) that have been previously published. From the 
model, it was observed that the puckered conformation of uro’gen III in the presence 
of SAM would result in a clash between the N-H group of ring A with the methyl 
group of the co-substrate (Figure 46A). Hence, it is concluded that, during actual 
catalysis when SAM is present in the active site, uro'gen III binds in a conformation in 
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which the ring A is flipped down in order to avoid this clash (Figure 46B). This 
conformation of uro’gen III with a planar arrangement of ring A potentially resembles 
that of the reaction transition state and might facilitate the formation of the new 
double bond between C-20 and C-1 upon proton abstraction from C-20. The flipping 
of the ring A also aids in positioning the C-2 atom closer to the methyl group of SAM 
that facilitates the nucleophilic attack. Subsequent to the methyl group transfer, a 
rearrangement of double bonds occurs within the tetrapyrrole macrocycle. Consistent 
with this hypothesis, it was observed that a double bond which was originally located 
between C-3 and C-4 in uro’gen III, is now found either between C-4 and C-5 or 
between C-4 and N-21 in the mono methylated intermediate precorrin-1 (Brunt et al., 
1989). This tautomerization of the tetrapyrrole might probably be influenced by the 
highly conserved Lys-72 of NirE, as previously proposed for the corresponding Lys-
270 of Salmonella enterica CysG (Stroupe et al., 2003). Unfortunately, in the NirE 
structure, this lysine residue is located on the flexible loop of domain A that could not 
be resolved. However, it has been reported that the K270I variant of CysG showed 
negligible SUMT activity (Stroupe et al., 2003) that reinforces the belief that Lys-72 
has an essential contribution in catalysis. Additionally, it is possible that the water 
molecules, which are present around uro’gen III, might also be involved in the 
tautomerization of precorrin-1. On completion of the first methylation, the mono-
methylated intermediate precorrin-1 (Figure 46C) and the reaction by-product SAH 
are released from the active site. In order to facilitate this release, the salt bridge 
between Arg*-149 and Asp*-150, which is observed in the absence of the bound 
uro'gen III is reformed. In order for the second methylation at C-7 to take place, a 
new SAM molecule needs to bind at the active site pocket followed by the binding of 
precorrin-1. Precorrin-1 binds to the enzyme in an orientation representing a 90° 
counter clockwise rotation with respect to the orientation of the initial substrate 
uro’gen III. As a result of this rotation, the methylene bridge C-5 now occupies the 
position that was initially occupied by C-20 during the first methylation. Hence, again 
Arg-111/Arg*-149 (Figure 45) would catalyze the proton abstraction from C-5 to 
initiate the second methyl group transfer. Finally, another rearrangement of double 
bonds would complete the synthesis of precorrin-2. 
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Figure 45. Proposed reaction mechanism of NirE (see text for detailed explanation).
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Figure 46. Model of SAM in the NirE active site and proposed conformation of bound uro’gen III 
in the presence of SAM in the NirE active site. The molecules are shown in stick representation. 
SAM/SAH is shown in light blue, uro’gen III/precorrin-1 in light orange. (A) Clash between the methyl 
group of modeled SAM and the N-H group of ring A in case that uro’gen III adopts its “two-up, two-
down” conformation. (B) Proposed conformation of uro’gen III in the presence of SAM. (C) Proposed 
conformation of precorrin-1 after the methyl transfer reaction and prototropic rearrangements. 
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